KÖZLEMÉNYEK JEGYZÉKE
Dr. Kiss Csongor
CIKKEK A tudományos fokozat megszerzése előtt lektorált tudományos folyóiratban in extenso megjelent cikkek: IF* 1. Toth FD, Szabo B, Kiss J, Vaczi L, Rethy A, Kiss A, Kovacs I, Rak K, Kiss C, Gallo RC: Studies on immunological markers of simian c-type viruses and human retrovirus htlv in adults and children with lymphoid leukemias and lymphoma. Acta Microbiol Hung, 1984, 31: 282-283. 0.303 2. Tóth FD, Szabó B, Váczi L, Kiss A, Kovács I, Rák K, Kiss C, Gallo R: Natural antibodies to simian type-C viruses and human retroviruses HTLV in patients with lymphoid malignancies. Acta Microbiol Hung, 1984, 31, 387-392. 0.303 3 . Mórocz I, Benkő I, Kiss C, Bársony Z: Fokális nodularis máj hyperplasia fiúgyermekben, Clostilbegyt kezelés után. Morphol Igazságü Szle, 1985, 25, 224-229. 4. Tóth FD, Váczi L, Szabó B, Kiss J, Réthy A, Kiss A, Telek B, Kovács I, Kiss C, Rák K: Detection of main core proteins of simian type-C viruses and human retrovirus HTLV and antibodies to them in patients with lymphoid malignancies. Acta Microbiol Hung, 1985, 32, 267-273. 0.260 5. Tóth FD, Váczi L, Szabó B, Kiss J, Rák K, Kiss A, Kovács I, Kiss C, Pecze K: Differential translation of virogenic and oncogenic sequences in malignant lymphoprolifetive disease and transfection of coding DNAs into NIH 3T3 cells. Acta Microbiol Hung, 1985, 32, 341-350. 0.260 6. Ilyés I, Sári B, Kiss C, Jászberényi J: A glucose-tolerancia, az inzulin-rezisztencia és a lipoprotein-anyagcsere eltéréseinek összefüggése a gyermekkori kövérségben. Orvosi Hetil, 1986, 127, 2117-2121. 7. Morocz I, Benkő I, Bársony Z, Kiss C: Focal nodular hyperplasia of the liver in a young boy after clomiphene treatment. Acta Paediatr Hung, 1986, 27, 15-21. 8 . Marton I, Harmati S, Kiss C: Immunologische Veranderungen bei Patienten mit periapikalem Granulom. Z.Stomatol, 1987, 84, 93-99. 9. Kiss C, Kovács I, Kerepesi T, Karmazsin L: Clinical significance of glucocorticoid receptors in acute leukaemias. Preliminary observations in Hungary and review of the literature. Acta Paediatr Hung, 1987, 28, 127-135. 10. Kiss C, Kovács I: Glukokortikoid receptorszám és sejtmembrán mikroviszkozitás vizsgálatok acut lymphoid leukaemias gyermekek mononuklearis sejtjein, remisszióban. Gyermekgyógyászat, 1987, 38, 283-286. 11. Makay A, Kiss C, Bobok I, Horváth A: Terápiás nehézségek a haemostasis összetett zavarával járó systemas lupus erythematosusos (SLE) betegünk esetében. Gyermekgyógyászat, 1987, 38, 287-290. 12. Márton I, Harmati S, Kiss C: Komplement szint és T-lymphocyta szám meghatározása krónikus periapicalis granulomás betegekben. Fogorvosi Szle, 1987, 80, 295-298. 13. Marton I, Kiss C, Balla G, Szabó T, Karmazsin L: Acute phase proteins in patients with chronic periapical granuloma before and after surgical treatment. Oral Microbiol Immunol, 1988, 3, 95-96. 1.246
14. Marton I, Sipka S, Harmati S, Kiss C: Chemilumineszenz im Vollblut bei Patienten mit periapikalem Granulom. Z Stomatol, 1989, 86, 191-195. 15. Márton I, Melczer K, Kiss C, Ilyés I: Congenitalis hypophosphatasia, mint a korai tejfog-vesztés lehetséges kóroka. Fogorvosi Szle, 1989, 82, 49-51. 16. Kiss C, Balázs M, Kovács I., Karmazsin L: Cell membrane fluidity in blast cells of children with various forms of acute leukaemia. Acta Paediatr Hung, 1990, 30, 291-302. 17. Kiss C, Balázs M, Keri-Fülöp I: Dexamethasone decreases membrane fluidity of leukemic cells. Leuk Res, 1990, 14, 221-225. 1.279 18. Kiss C, Balázs M: Changes in leukemia cell membrane fluidity induced by growthrestrictive and permissive culture conditions. Leuk Res, 1990, 14, 293-294. 1.279 19. Kiss C, Kiss A, Kovács I, Oláh É, Balogh E, Karmazsin L: Hybrid acut leukaemias gyermek esete. Orvosi Hetil, 1990, 131, 2431-2433. 20. Marton I, Kiss C, Szabó T: Akut-fázis fehérjék szerepe a kronikus periapikalis granuloma patogenezisében. Fogorvosi Szle, 1990, 83, 235-239. 21. Kiss C: Clonal growth and self-renewal of human myeloid leukemia cell lines (BRM and DD) in serum-free semi-solid culture. Blut, 1990, 61, 317-319. 1.729 22. Kiss C, Kovács I, Karmazsin L: Glukokortikoid receptorszint prospektív utánkövetés vizsgálata akut leukamiás gyermekekben. Gyermekgyógy, 1990, 41, 273-279. A tudományos fokozat megszerzését követően lektorált tudományos folyóiratban in extenso megjelent cikkek: 2 3 .Kiss C, Kovács I, Karmazsin L: Decreased sensitivity to cytostatic drugs in glucocorticoid receptor-free AML cells. Clinical and experimental observations. Acta Pediatr Hung, 1991, 32, 223-231. 24. Marton IJ, Kiss C: Influence of surgical treatment of periapical lesions on serum and blood levels of inflammatory mediators. Internatl Endod J, 1992, 25, 229-233. 0.253 25. Kiss C, Cesano A, Zsebő KM, Clark SC, Santoli D: Human stem cell factor (c-kit ligand) induces an autocrine loop of growth in a GM-CSF-dependent megakaryocytic leukemia cell line. Leukemia, 1993, 7, 235-240. 1.876 26. Kiss C: Impaired capacity of multidrug resistance-related cytotoxic drugs to inhibit colony formation of dexamethasone-resistant human leukemic cell lines. Cancer Invest, 1993, 11, 358-360. 1.181 27. Marton IJ, Kiss C: Characterization of inflammatory cell infiltrate in dental periapical lesions. Intenatl Endod J, 1993, 26, 131-136. 0.198 28. Marton IJ, Balla G, Hegedűs C, Redl P, Szilágyi Z, Karmazsin L, Kiss C: The role of reactive oxygen intermediates in the pathogenesis of chronic apical periodontitis. Oral Microbiol.Immunol, 1993, 8, 254-257. 1.475 29. Kiss C: Regulation of gene expression in human leukemic cell lines: effect of c-kit ligand. Alpe Adria J Med, 1994, 49, 42-44. 30. Kiss C, Surrey S, Schreiber AD, Schwartz E, McKenzie SE: Human c-kit ligand (stem cell factor) induces platelet Fc receptor expression in megakaryoblastic cells. Exp Hematol, 1996, 24, 1232-1237. 3.198 31. Vályi-Nagy I, Jákó J, Domján G, Kiss C, Pető M: Idiopathiás hypereosinophil syndroma. Orvosképzés, 1996, 71, 259-265.
3 2 . Pap Z, Ajzner É, Kiss C , Emődy J, Závodszky I, Horváth A, Muszbek L: Thrombocytafunkció-zavar albínó gyermekekben. Orvosi Hetil, 1997, 138, 467-471. 33. Majoros J, Kappelmayer J, Kiss A, Kiss C, Kiss M, Jakó J, Muszbek L: Áramlási citometria alkalmazása kevert fenotípusú leukémiák diagnosztikájában. Klin Kísérl Lab Med, 1997, 24, 20-26. 34. Alberth M, Nemes J, Radics T, Kiss C: Egy amegakaryocytás thrombocyto-peniás purpurához társult zománcfejlődési rendellenesség esete. Fogorvosi Szle, 1997, 90, 131135. 35. Balogh E, Swanton S, Kiss C, Jakab Z, Secker-Walker LM, Olah É: A 2q21-qter regio trisomiájának szerepe a hepatoblastoma kialakulásában. Orvosi Hetil, 1997, 138, 31793183. 36. Olah É, Balogh E, Kajtár P, Pajor L, Jakab Z, Kiss C: Diagnostic and prognostic significance of chromosome abnormalities in childhood acute lymphoblastic leukemia (ALL). Annals New York Acad Sci, 1997, 824, 8-27. 0.903 37. Karászi É, Kiss C, Jakab Z, Szegedi I, Hevessy Z, Kappelmayer J: Gyermekkori akut leukémiák vizsgálata sejtfelszíni markerek és ploiditás alapján. Gyermekgyógy, 1998, 49, 319-329. 38. Jakab Z, Balogh E, Kiss C, Földi J, Oláh É: Agranulocytosis ? Myelodysplasiás syndroma ? Acut leukemia ? Új diagnosztikai eljárások felhasználása gyermekkori leukemiák kórismézésében egy eset kapcsán. Gyermekgyógy, 1998, 49, 365-372. 39. Balogh E, Swanton S, Kiss C, Jakab Z, Secker-Walker LM, Olah É: Fluorescnce in situ hybridization reveals trisomy 2q by insertion into 9p in hepatoblastoma. Cancer Genet Cytogenet, 1998, 102, 148-150. 1.554 40. Marton IJ, Dezső B, Radics T, Kiss C: Distribution of interleukin-2 receptor α chain and class II antigen expressing cells in chronic human periapical lesions. Oral Microbiol Immunol, 1998, 13, 259-262. 1.347 41. Kiss C: Interferons in pediatric oncology - End of the beginning or beginning of the end ? Med Ped Oncol, 1998, 30, 364-366. 1.783 42. Kiss C, Szegedi I, Jakab Z, Kiss M, Felszeghy E, Oláh É: Kolónia-stimuláló faktorok alkalmazása másodlagos granulocytopeniás gyermekekben. Magyar Belorv Arch, 1998, 51, 237-242. 43. Oláh VA, Szegedi I, Nagy E, Varga J, Kiss C, Oláh É: Plasma levels of anthracyclines and their effect on the kidney. Adv Chromatogr Electrophor Relat Separat Methods, 1998, 1, 161-167. 44. Marton I, Bagyi K, Radics T, Kiss C: Az apicalis periodontitis kialakulása és szervezetre gyakorolt hatása. Fogorv Szle, 1998, 91, 269-273. 45. Jakab Z, Balogh E, Kiss C, Pajor L, Oláh É: Biclonal chromosomal aberrations in a child with MDS. Cancer Genet Cytogenet, 1999, 108, 13-18. 1.756 46. Mikala G, Xie J, Berencsi G, Kiss C, Márton I, Domján G, Vályi-Nagy I: Human herpesvirus 8 in hematologic diseases. Pathol Oncol Res, 1999, 5, 73-79. 1.162 47. Kiss C: Sürgősségi ellátást igénylő gyermekhematológiai állapotok. Focus Med, 1999, 1, 29-37. 48. Máron IJ, Radics T, Szakáll S, Kiss C: A sejtes összetétel, az aktivált állapotú sejtek vizsgálata granuloma apicaléban. Fogorv Szle, 1999, 92, 379-385. 49. Kerenyi A, Schlammadinger A, Ajzner E, Szegedi I, Kiss C, Pap Z, Boda Z, Muszbek L: Comparison of PFA-100 closure time and template bleeding time in patients with
inherited disorders causing defective platelet function. Thrombosis Res, 1999, 96, 487492. 1.207 50. Kerényi A, Szegedi I, Sarudi S, Kappelmayer J, Kiss C, Muszbek L: A Glantzmann thrombasthenia II. tipusa. Esetleírás. Klin Kísérl Lab Med, 1999, 25, 162-168. 51. Márton IJ, Rot A, Schwarzinger E, Szakáll S, Radics T, Vályi-Nagy I, Kiss C: Differential in situ distribution of IL-8, MCP-1 and Rantes in human chronic periapical granuloma. Oral Microbiol Immunol, 2000, 15, 63-65. 1.419 52. Marton IJ, Kiss C: Protective and destructive immune reactions in apical periodontitis. Oral Microbiol Immunol, 2000, 15, 139-150. 1.419 53. Kiss C, Mészner Z: Gyermekkori lázas neutropeniás epizódok empirikus aniinfektív gyógykezelése. Gyermekgyógy, 2000, 51, 112-121. 54. Balogh E, Kiss C, Jakab Z, Oláh É: Citogenetikai vizsgálatok jelentősége gyermekkori myelodysplasiás syndromában. Gyermekgyógy, 2000, 51, 130-136. 55. Jakab Z, Balogh E, Kiss C , Oláh É: Gyógyszerrezisztencia-vizsgálat MTT-teszttel gyermekkori acut lymphoid leukemiában. Gyermekgyógy, 2000, 51, 137-144. 56. Győrfy Á, Árvai K, Erdész C, Kiss C, Ilyés I: Extrém fokú hypernatraemia az osmoreguláció károsodása következtében: hypothalamikus hypodypsia szindroma. Gyermekgyógy, 2000, 51, 158-162. 57. Kiss C: A haemolyticus anaemia. 1. rész. Kommentár. Gyermekgyógy Továbbképző Szle, 2000, 5, 87-91. 58. Kiss C: A haemolyticus anaemia. 2. rész. Kommentár. Gyermekgyógy Továbbképző Szle, 2000, 5, 124-126. 59. Benkő I, Kovács P, Szegedi I, Megyeri A, Kiss A, Balogh E, Olah E, Kappelmayer J, Kiss C: Effect of myelotropic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia. N-S Arch Pharnmacol, 2001, 363, 499-508. 2.472 60. D’Angio GJ, Kiss C: Series Co-Editor’s note. Med Pediatr Oncol 36:647-648, 2001. Corrigendum. Med Pediatr Oncol, 2001, 37, 81-81. 1.114 61. Redl P, Gyulahazi J, Kiss C, Marton I: Fibromatosis in the paramandibular region. Med Pediatr Oncol, 2001, 37, 75-76. 1.114 62. Kappelmayer J, Kiss A, Karászi É, Jakó J, Kiss C : Identification of P-selectin glycoprotein ligand-1 as a useful marker in acute myeloid leukaemias. Br J Haematol, 2001, 115, 903-909. 2.815 63. Kiss C: International note. Third joint meeting of Rumanian and Hungarian Pediatric hematologists/oncologists. Med Pediatr Oncol, 2002, 38, 368-368. 1.216 64. Jakab Z, Balogh E, Kiss C , Olah E: Epidemiologic studies in a population based childhood cancer registry in North-East Hungary. Med Pediatr Oncol, 2002, 38, 338-344. 1.216 65. Jakab Z, Balogh E, Karászi E, Kappelmayer J, Kiss C, Oláh E: Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL) – do outcomes differ from t(4;11)? Med Pediatr Oncol, 2002, 39, 63-65. 1.216 66. Jakab Z, Szegedi I, Balogh E, Kiss C , Oláh E: Duchenne muscular dystrophyrhabdomyosarcoma, ichthyosis vulgaris-acute monoblastic leukemia: association of rare genetic disorders and childhood malignant diseases. Med Pediatr Oncol, 2002, 39, 66-68. 1.216
67. Kiss C, Kiss M, Szegedi I, Árvai K, Tóth J, Oláh E: Interferon-alpha therapy in children with malignant diseases: clinical experiences in 24 patients treated in a single pediatric oncology unit. Med Pediatr Oncol, 2002, 39, 115-119. 1.216 68. Kiss C: A vérszegénység kezelése a gyermekorvosi gyakorlatban: 1. rész. Kommentár. Gyermekgyógy Továbbképző Szle, 2002, 7, 229-232. 69. Kiss C: A vérszegénység kezelése a gyermekorvosi gyakorlatban: 21. rész. Kommentár. Gyermekgyógy Továbbképző Szle, 2002, 7, 292-294. 70. Győrfy A, Kovács T, Szegedi I, Oláh E, Kiss C: Sweet syndrome associated with 13-cisretinoic acid (isotretinoin) therapy. Med Pediatr Oncol, 2003, 40, 135-136. 1.737 71. Radics T, Kiss C, Tar I, Marton IJ: Interleukin-6 and GM-CSF in apical periodontitis: correlation with clinical and histologic findings of the involved teeth. Oral Microbiol Immunol, 2003, 18, 9-13. 1.242 72. Kiss C: Malignus vérképzőrendszeri zavarok korai tünetei. Gyermekorvos továbbképzés, 2003, 2, 55-59. 73. Kiss C, Benkő I, Kovács P: Leukemic cells and the cytokine patchwork. Pediatr Blood Cancer, 2004, 42, 113-121. 1.512 74. Árvai K, Tóth J, Németh T, Kiss C, Molnár P, Oláh É: Csecsemőkori nyaki lokalizációjú neuroblastoma. Magyar Onkológia, 2004, 48, 89-95. 75. Kiss C: Vashiány, vashiányos vérszegénység gyermekkorban. Családorvosi Fórum 10:2628, 2004. 76. Alberth M, Kovalecz G, Nemes J, Math J, Kiss C, Marton IJ: Oral health of long-term childhood cancer survivors. Pediatr Blood Cancer 2004, 43, 88-90. 1,512 77. Bárdi E, Bobok I, Oláh VA, Oláh É, Kappelmayer J, Kiss C: Cystatin C is a suitable marker of glomerular function in children with cancer. Pediatr Nephrol 19:1145-1147, 2004. 1,440 78. Szántó J, András C, Tsakiris J, Gomba S, Szentirmay Z, Bánlaki S, Szilágyi I, Kiss C, Antall P, Horváth A, Lengyel L, Castiglione-Gertsch M: Secretory breast cancer in a 7.5year old boy. Breast 13: 439-442, 2004. 0,760 79. Bárdi E, Oláh VA, Bartyik K, Endreffy E, Jenei C, Kappelmayer J, Kiss C: Late effects on renal glomerular and tubular function in childhood cancer survivors. Pediatr Blood Cancer 43: 668-673, 2004. 1,512 80. Kiss C: Cell-to-cell interactions. Endod Topics 8: 88-103, 2004. 81. Bárdi E, Bobok I, Kiss C: Daganatos gyermekek vesekárosodása. A megelőzés és a kezelés lehetőségei. – összefoglaló klinikai tanulmány. Hypertonia és Nephrologia 2004; 8:162-170 82. Bárdi E, Szegedi I, Kiss C: Harmadik folyadéktér szerepe a methotrexát toxicitás kialakulásában, esetbemutatások kapcsán. Gyermekgyógyászat 2005;56:438-442 83. Losonczy G, Rosenberg N, Kiss C, Kappelmayer J, Vereb G, Kerenyi A, Balogh I, Muszbek L: A novel homozygous mutation (1619delC) in GPllb gene associated with Glanzmann thrombasthenia, the decay of GPllb-mRNA and the synthesis of a truncated GPllb unable to form complex with GPllla. Thromb Haemost 93: 904-909, 2005. 3.056 84. Bardi E, Jenei C, Kiss C: Polymorphism of angiotensin converting enzyme is associated with severe circulatory compromise in febrile neutropenic children with cancer. Pediatr Blood Cancer 45: 217-221, 2005. 1.512
85. Kappelmayer J, Simon A, Katona E, Szanto A, Nagy L, Kiss A, Kiss C, Muszbek L: Coagulation factor XIII-A - A flow cytometric intracellular marker in the classification of acute myeloid leukemias. Thromb Haemost 94: 454-459, 2005. 3.056 86. Müller J, Kovács G, Jakab Z, Rényi I, Galántai I, Békési A, Kiss C, Nagy K, Kajtár P, Bartyik K, Masát P, Magyarosy E: Az ALL-BFM-95 protokollal szerzett hazai eredmények akut lymphoblastos leukaemiás gyermekek kezelésében. Orvosi Hetil 146: 75-80, 2005. 87. Kiss C: Myelodysplasiás szindrómák gyermekkorban. Gyermekgyógy Továbbképző Szle 10:145-151, 2005. 8 8 .Szegedi I, Kiss C: Mieloproliferatív szindrómák gyermekkorban. Gyermekgyógy Továbbképző Szle 11:149-155, 2006. 89. Muller J, Garami M, Hauser P, Schuler D, Csoka M, Kovacs G, Marosi A, Galantai I, Bekesi A, Kajtar P, Kiss C S , Nagy K, Bartyik K, Masath R, Krivan G: Hungarian experience with Langerhans cell histiocytosis in childhood. Pediatr Hemat Oncol 23: 135142, 2006. 0.529 90. Sohajda Z, Damjanovich J, Bardi E, Szegedi I, Berta A, Kiss C: Combined local treatment and chemotherapy in the management of bilateral retinoblastomas in Hungary. J Pediatr Hematol Oncol 28: 399-401, 2006. 1.170 91. Kiss F, Hevessy Z, Veszprémi A, Katona E, Kiss C, Vereb G, Muszbek L, Kappelmayer J: Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A. Thromb Haemost 96: 176-182, 2006. 2.803 § 92. Szegedi I, Kiss C , Karaszi E, Vamosi G, Szollosi J, Kovacs P, Benko I: Differential regulation of umbilical cord blood and leukemic B cells by interferon-alpha (IFN-alpha): Observations in cultured cells. Pathol Oncol Res 12: 159-163, 2006. 1.241 93. Majoros L, Szegedi I, Kardos G, Erdesz C, Konya J, Kiss C: Slow response of invasive Candida krusei infection to amphotericin B in a clinical time-kill study. Eur J Clin Microbiol Infect Dis 25: 803-806, 2006. 2.330 94. Alberth M, Majoros L, Kovalecz G, Borbás E, Szegedi I, Marton IJ, Kiss C: Significance of oral Candida infections in children with cancer. Pathol Oncol Res 12: 237-241, 2006. 1.241 95. Renyi I, Bardi E, Udvardi E, Kovacs G, Bartyik K, Kajtar P, Masat P, Nagy K, Galantai I, Kiss C: Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin’s lymphoma. Pathol Oncol Res 13:57-62, 2007. 1.272 96. Szegedi I, Benkő I, Merő G, Princzinger A, Kappelmayer J, Kiss C: Long-lasting partial remission by interferon-alpha in a child with essential thrombocythemia. Pediatr Blood Cancer 49:744-747, 2007 2.164 97. Bardi E, Bobok I, Olah AV, Kappelmayer J, Kiss C: Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer. Pathol Oncol Res 13:249-253, 2007. 1.272 98. Kiss F, Buslig J, Szegedi I, Scholtz B, Kappelmayer J, Kiss C: Early relapse after Rituximab chemoimmunotherapy. Pediatr Blood Cancer 50: 372-375, 2008. 2.164 99. Bereczky Z, Bárdos H, Komáromi I, Kiss C, Haramura G, Ajzner É, Ádány R, Muszbek L: Factor XDebrecen: Gly204Arg mutation in factor X causes the synthesis of a nonsecretable protein and severe factor X deficiency. Haematologica 93:299-302, 2008. 5.516
100. Tar I, Kiss C, Marodi L, Marton IJ: Oral and dental conditions of children with selective IgA deficiency. Pediatr Allergy Immunol 19: 33-36, 2008. 2.454 101. Kiss F, Simon Á, Csáthy L, Hevessy Z, Katona É, Kiss C, Kappelmayer J: A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII. Cytometry A, 73A: 194-201, 2008. 2.978 102. Jozsa T, Dienes B, Telek A, Hargitai Z, Por A, Kiss C: Differential expression of androgen and estrogen receptor of appendix testis in patients with descended and undescended testes. Internatl J Urol 15: 171-174, 2008. 0.769 103. Kiss C, Jakab Z, Bakos-Tóth M, Bartyik K, Békési A, Galántai I, Garami M, Kriván G, Magyarosy E, Masát P, Nagy K, Oláh É, Ottóffy G, Péter G, Rényi I, Kajtár P, Kovács G: Rosszindulatú daganatos megbetegedésben szenvedő gyermekbetegek komplex kivizsgálása, gyógykezelése és gondozása Magyarországon. Gyermekgyógyászat 59: 137142, 2008. 104. Nemes JA, Redl P, Boda R, Kiss C, Marton IJ: Oral cancer report from Northeastern Hungary. Pathol Oncol Res 14: 85-92, 2008. 1.272 105. Kiss C: Vörösvértest-transzfúzió. Kommentár. Gyermekgyógy Továbbképző Szle 13: 16-17, 2008. 106. Szegedi I, Katona K, Horváth A, Molnár A, Aradi J, Kiss C: Bcl-2 antisense oligonucleotide inhibits the proliferation of childhood leukemia/lymphoma cells of the Bcell lineage. Pathol Oncol Res 14:275-279, 2008. 1.272 107. Erdilyi DJ, Kamory E, Csokay B, Andrikovics H, Tordai A, Kiss C, Filni-Semsei A, Janszky I, Zalka A, Fekete G, Falus A, Kovacs GT, Szalai C: Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy. Pharmacogenomics J 8: 321-327, 2008. 4.968 §
Megosztott első szerző
In extenso közlemények impakt faktora*:
92.749
Első/utolsó szerzőként jegyzett cikk: Társszerzőként jegyzett cikk:
63 44
Magyar nyelvű cikk: Idegen nyelvű cikk:
38 69
A tudományos fokozat megszerzése előtt megjelent cikk: A tudományos fokozat megszerzése után megjelent cikk:
22 85
Az utolsó 5 évben megjelent cikk: Az utolsó 2 évben megjelent cikk: *Impakt faktor (IF) az MTA szabályai szerint megadva: a 2007-ig megjelent közlemények esetében a folyóirat megjelenésének éve, illetőleg, korábbi évfolyamok esetében az IF kiszámításának első éve szerint (Oral Microbiology Immunology: 1990, Pathology Oncology Research: 2005, Pediatric Blood and Cancer: 2005). A 2007 után megjelent közlemények esetében az utolsó elérhető, 2007-es lista alapján.
KÖNYVRÉSZLETEK A tudományos fokozat megszerzése előtt megjelent könyvrészlet: K1. Kiss C, Karmazsin L.: Aplasztikus anemia. In: Kaldor A, Gergely J, Kulka F (eds.): Az orvostudomány aktuális problémái. Medicina, Budapest, 1986. pp. 85-104. A tudományos fokozat megszerzéssét követően megjelent könyvrészletek: K2. Kiss C: A gyermekgyógyászati farmakoterápia speciális szempontjai. Hematológia. In: Bakó G (ed): Farmakoterápia. Budapest, 1997. MedicÌna, pp. 408-411. K3. Kiss C: A cytostaticus kezelés alapelvei gyermekkorban. In: Bakó G (ed.): Farmakoterápia. Budapest, 1997. MedicÌna, pp. 412-414. K4. Kiss C: A vérképzőrendszer betegségei. In: Maródi L (ed.): Gyermekgyógyászat. Budapest, 1998. MedicÌna, pp. 416-453. K5. Kiss C: Gyermekgyógyászat. Hematológiai és daganatos megbetegedések. In: de Chatel R, Ember I, Szarvas F, Udvardy M, Zoltán ÖT (eds): Általános orvosi ismeretek. Egészségügyi felsőoktatási záróvizsga tesztkérdésgyűjtemények. Budapest, 1999. Medicina, pp. 1369-1382. K6. Kiss C: Early empiric and subsequent anti-infective therapy of febrile neutropenic children on aggressive cytotoxic therapy. In: Maródi L (ed): Emerging infectious diseases in Eastern-Central Europe. Budapest, 2000. Medicina, pp. 222-234. K7. Kiss C: Gyermekgyógyászat. Vérképző szervi és daganatos betegségek. In: Boda Z, Bakó G (eds): Klinikai alapismeretek fogorvos- és gyógyszerészhallgatóknak. Budapest, 2001. Medicina, pp. 511-544. K8. Kiss C: Gyermekgyógyászat. A szájüreg és a környező testtájak elváltozásai gyermekkori betegségekben. In: Boda Z, Bakó G (eds): Klinikai alapismeretek fogorvosés gyógyszerészhallgatóknak. Budapest, 2001. Medicina, pp. 545-561. K9. Kiss C: A vérképzőrendszer betegségei. In: Maródi L (ed.): Gyermekgyógyászat. Második, bővített, átdolgozott kiadás. Budapest, 2002. MedicÌna, pp. 458-495. K10. Kiss C: Gyermekgyógyászat. Hematológiai és daganatos megbetegedések. In: de Chatel R, Ember I, Szarvas F, Udvardy M, Zoltán ÖT (eds): Egészségügyi felsőoktatási záróvizsga tesztkérdésgyűjtemények. Általános orvosi ismeretek. 2., átdolgozott és magyarázatokkal bővített kiadás. Budapest, 2003. Medicina, pp. 1384-1397. K11. Kiss C: Gyermekgyógyászat. Hematológiai és daganatos megbetegedések. In: de Chatel R, Ember I, Szarvas F, Udvardy M, Zoltán ÖT (eds): Egészségügyi felsőoktatási záróvizsga tesztkérdésgyűjtemények. Általános orvosi ismeretek. Magyarázatok. 2., átdolgozott és magyarázatokkal bővített kiadás. Budapest, 2003. Medicina, pp. 21962003. K12. Kiss C: Hematológia. In: Bakó G (szerk): Farmakoterápia. 2. átdolgozott és bővített kiadás. Budapest, 2003, Medicina, pp. 439-444. K13. Kiss C: Bőrvérzések: purpurák és petechiák. In: Oláh É (szerk.): Gyermekgyógyászati kézikönyv. Budapest, 2004. Medicina, pp. 413-414. K14. Kiss C: Újszülöttkori hematológiai megbetegedések. In: Oláh É (szerk.): Gyermekgyógyászati kézikönyv. Budapest, 2004. Medicina, pp. 1201-1203.
K15. Kiss C: Retinoblastoma. In: Oláh É (szerk.): Gyermekgyógyászati kézikönyv. Budapest, 2004. Medicina, pp. 1437-1438. K16. Kiss C: A vérképzés élettana és a vérképzőrendszer vizsgálatára szolgáló módszerek. In: Oláh É (szerk.): Gyermekgyógyászati kézikönyv. Budapest, 2004. Medicina, pp. 15811582. K17. Kiss C: Anaemiák. In: Oláh É (szerk.): Gyermekgyógyászati kézikönyv. Budapest, 2004. Medicina, pp. 1583-1622. K18. Kiss C: A fehérvérsejtek nem klonális eltérései. In: Oláh É (szerk.): Gyermekgyógyászati kézikönyv. Budapest, 2004. Medicina, pp. 1623-1628. K19. Kiss C, Kovács G, Garami M, Szegedi I, Hauser P, Müller J, Nagy K. Gyermekkori rosszindulatú daganatos megbetegedések. In: Szántó J (ed): Klinikai onkológia a gyakorlatban. Budapest, 2005. Medicina, pp. 421-422. K20. Kiss C: A vérképző rendszer malignus betegségei. In: Szántó J (ed): Klinikai onkológia a gyakorlatban. Budapest, 2005. Medicina, pp. 423-440. K21. Garami M, Nagy K, Kiss C: Az idegrendszer daganatai a gyermekkorban. In: Szántó J (ed): Klinikai onkológia a gyakorlatban. Budapest, 2005. Medicina, pp. 445-452. K22. Kiss C: A thrombocyta-funkció zavarai. In: Lehoczky D (szerk): Hematológiai betegségek kezelése. A Szakmai Kollégium és a Tudományos Társaság kezelési javaslata. Documed, Budapest, 2006. pp. 239-240. K23. Kiss C: Myeloproliferaiv kórképek és myelodysplasia szindróma (MDS). In: Lehoczky D (szerk): Hematológiai betegségek kezelése. A Szakmai Kollégium és a Tudományos Társaság kezelési javaslata. Documed, Budapest, 2006. pp. 245-246. K24. Kovács G, Masát P, Kiss C: Acut leukaemiák. In: Lehoczky D (szerk): Hematológiai betegségek kezelése. A Szakmai Kollégium és a Tudományos Társaság kezelési javaslata. Documed, Budapest, 2006. pp. 247-253. K25. Kiss C, Masát P: Gyermekkori heveny myeloid leukémia. In: Dank M, Demeter J (szerk): Hatóanyagok, készítmények, terápia. Fókuszban az onkológia és az onkohematológia. MeLinda Kiadó és Reklámügynökség, Budapest, 2006, pp. 653-658. K26. Kiss C: Myeloproliferatív kórképek és myelodiszpláziás szindrómák gyermekkorban. In: Dank M, Demeter J (szerk): Hatóanyagok, készítmények, terápia. Fókuszban az onkológia és az onkohematológia. MeLinda Kiadó és Reklámügynökség, Budapest, 2006, pp. 659-662. K27. Kiss C: Immunthrombocytopeniák a gyermekkorban. In: Boda Z (szerk): Thrombosis és vérzékenység. Medicina, Budapest, 2006. pp. 208-218. K28. Kiss C: Gyermekgyógyászati farmakológia. Hematológia. In: Bakó G (ed): Farmakoterápia. Harmadik, átdolgozott és bővített kiadás. MedicÌna, Budapest, 2007. pp. 454-459.
ABSZTRAKTOK A tudományos fokozat megszerzése előtt, lektorált folyóiratban megjelent, citálható absztraktok: IF* A1. Tóth M, Varga P, Kiss C, Gönczi F, Kövér A: Effect of tetracaine on some properties of human red blood cells. Acta Physiol Acad Sci Hung, 1979, 52, 269-270. 0.378 A2. Kiss C, Tóth M, Kövér A: Cholinesterase of erythrocyte ghosts. Acta Physiol Acad Sci Hung , 1979, 53, 125. 0.378 A3. Mátyus L, Kiss C, Tóth M: Study on the hydrolysis of fluoresceindiacetate catalysed by human erythrocyte membrane. Proc. 19th Hung. Ann. Meet. Biochem., Budapest, 1979, pp. 87-88. A4. Muszbek L, Kiss C, Ádány R, Fényi A, Ozsvári Z, Kovács I: Thrombocyta "release" zavarok differencial diagnosztikája. Magyar Pediáter, 1983, 17, 258. A5. Kiss C, Adany R, Muszbek L : Hermansky-Pudlak syndrome with decreased factor-XI level. Thromb Haemost 1983, 50: 445-445 3.456 A6. Kiss C, Karmazsin L, Boján F, Mándi B, Ilyés I: Hormone receptors, membrane fluidity and cell growth of leukemic cells. Med Peidatr Oncol, 1987, 15, 355. 0.865 A7. Kiss C, Karmazsin L: Leukaemia sejtvonalak vizsgálatával szerzett tapasztalataink. Magyar Ped, 1988, 22, 91. A8. Kiss C, Balázs M, Karmazsin L, Mándi B: Regulation of glucocorticoid receptor content and membrane fluidity by changing the proliferative activity in BR cells. Blood Cells, 1988, 14, 562. 1.0 A9. Kiss C, Fliedner TM: Hemopoetic growth factors modulate colony formation of cell lines established from a patient with hybrid acute leukemia (HAL). Leuk Res, 1989, 13, 9. 1.356 A10.Marton I, Kiss C: Immunoregulatory and inflammatory changes in apical periodontitis. Int Endodont J, 1990, 23, 62. 0.576 A tudományos fokozat megszerzését követően, lektorált folyóiratban megjelent, citálható absztraktok: A11.Kiss C, Cesano A, Santoli D: Stem cell factor (SCF) is a potent stimulator of megakaryoblastic and T-lymphoblastic pediatric leukemic cell lines. Med Pediatr Oncol, 1992, 20, 380. 1.027 A12.Kiss C, Surrey S, Cassel DL, Keller MA, Santoli D, Schreiber AD, Schwartz E, McKenzie SE: Regulation of Fc RIIA expression in human leukemic cell lines: effect of ckit ligand (KL) J Immunol, 1993, 150, A88. 7.065 A13.Kiss C, Cesano A, Santoli D: Human c-kit ligand (KL) induces GM-CSF production in cytokine-dependent leukemic cell lines. Paediatr Paedol, 1994, 29, 58. A14.Kiss C, Surrey S, Casssel DL, Keller MA, Santoli D, Schreiber AD, Schwartz E, MecKenzie SE: C-kit ligand (KL) regulates Fc gamma RIIA expression in human leukemic cell lines. Med Ped Oncol, 1994, 23, 183. 1.341 A15.Márton IJ, Johnson S, Kiss C, Knowles BB: Mice transgenic fro and SV40 tumor antigen (Tag) hybrid gene as an animal model for tumorigenicity and autoimmunity. Med Pediatr Oncol, 1995, 25, 325. 1.543
A16.Kiss C, Kovács I: Myelotoxicity of dibromodulcitol (Elobromol) treatment in the management of malignant CNS tumors. Med Pediatr Oncol, 1995, 25, 339. 1.543 A17.Olah E, Balogh E, Jakab Z, Kiss C: Initial genetic diagnosis in acute lymphoblastic leukemia (ALL). Pediatr Res, 1996, 39, 947. 2.886 A18.Szegedi I, Jakab Z, Kiss M, Felszeghy E, Oláh É, Kiss C: Idarubicin in pediatric ALL and non-Hodgkin’s lymphoma: Induction therapy in relapsed disease. Med Pediatr Oncol, 1997, 29, 474. 1.693 A19.Jakab Z, Balogh E, Kiss C, Pajor L, Oláh É: Biclonal chromosomal abnormality in a child with MDS. Med Pediatr Oncol , 1997, 29, 461. 1.693 A20.Oláh É, Balogh E, Kiss C, Jakab Z, Pajor L: Diagnostic and prognostic significance of the initial genetic abnormalities in childhood acute lymphoblastic leukemia (ALL). Med Pediatr Oncol, 1997, 29, 475. 1.693 A21.Kiss C, Nemes Z, Márton IJ, Vályi-Nagy I, Rot A: Expression of chemokine family of inflammatory cytokines in Rosai-Dorfman-type histiocytosis. Med Pediatr Oncol, 1997, 29, 461. 1.693 A22.Benkő I, Kovács P, Megyeri A, Szegedi I, Kiss C: Stimulation of blast cells in vitro in children with acute lymphoblastic leukaemia by granulocyte-macrophage colony stimulating factor (rhGM-CSF), granulocyte colony stimulating factor (rhG-CSF) and stem cell factor (SCF). N-S Arch Pharmacol, 1997, 356, 77-77. 2.492 A23.Oláh VA, Szegedi I, Nagy E, Kiss M, Kiss C, Oláh É: Új diagnosztikai és preventív lehetőségek anthracyclin kezelések során. Klin Kísérl Lab Med, 1997, 24, 103. A24.Márton IJ, Rot A, Radics T, Vályi-Nagy I, Kiss C: Expression of chemokine family of inflammatory cytokines in chronic apical periodontitis. 8 Bienn C Eur Soc E, 1997, 13. A25.Balogh E, Swanton S, Kiss C, Jakab Z, SeckerWalker LD, Olah E: FISH confrms the importance of trisomy 2q im hepatoblastoma. Cytogenet Cell Genet, 1997, 77, P352P352. 2.466 A26.Márton IJ, Rot A, Radics T, Vályi-Nagy I, Kiss C: Expression of chemokine family of inflammatory cytokines in chronic apical periodontitis. Int Endod J 31: 205, 1998. 0.718 A27.Kiss C, Benkő I, Kiss M, Jakab Z, Szegedi I: Interferons in pediatric oncology. Med Pediatr Oncol, 1998, 31, 349. 1.783 A28.Kiss C, Damjanovich J, Kolozsvári L, Berta A: Combined chemotherapy and local treatment of bilateral retinoblastoma. Med Ped Oncol, 1998, 31, 349. 1.783 A29.Karaszi E, Hevessy Z, Kiss C, Kappelmayer J: Prognostic value of surface markers, DNA aneuploidy and cell cycle analysis in acute childhood leukemias. Br J Haematol, 1998, 102, 230-231. 3.209 A30.Kiss C, Benkő I, Karászi É, Vámosi G, Szegedi I, Kappelmayer J, Szöllősi J: Interferonα -2b induces growth inhibition, apoptosis and differentiation in human B-cell lineage leukemic cell lines. Med Pediatr Oncol, 1999, 33, 271. 1.518 A31.Balogh E, Kiss C, Jakab Z, Pajor L, Olah E: Cytogenetic findings in 15 children with myelodysplastic syndromes. Cytogenet Cell Genet, 1999, 85, 242. 1.604 A32.Olah E, Balogh E, Kajtar P, Kiss C, Jakab Z, Szabo P, Pajor L: Diagnostic and prognostic significance of initial genetic studies in acute lymphocytic leukemia (ALL). Data and experiences obtained between 1993 and 98 in ten centers of the Hungarian Oncological Study Group. Cytogenet Cell Genet, 1999, 85, 323. 1.604
A33.Szegedi I, Benko I, Karaszi E, Vamosi G, Kappelmayer J, Szollosi J, Kiss C: Interferonalpha-2b induces growth inhibition, apoptosis, and differentiation in human B-cell-lineage leukemic cell lines. Cytometry, 2000, 42, 156. 2.557
A34.Benkő I, Kovács P, Szegedi I, Megyeri A, Kiss A, Balogh E, Oláh E, Kappelmayer J, Kiss C: Effect of myelopoietic and pleiotropic cytokines on colony formation of blast cells of children with acute lymphoblastic leukemia. Med Pediatr Oncol, 2000, 35, 226. 1.301 A35.Balogh E, Jakab Z, Kiss C, Oláh E: Cytogenetic investigations in childhood myelodysplastic syndrome. Med Pediatr Oncol, 2000, 35, 328. 1.301 A36.Jakab Z, Balogh E, Kiss C, Olah E: Drug resistance determination in childhood lymphoid leikemia by MTT-test. Cytometry, 2001, 46, 208-208. 2.22 A37. Kiss C, Szegedi I, Katona K, Aradi J, Kappelmayer J: BCL-2 antisense oligonucleotid inhibits clonal growth of leukemia cell lines. Pediatr Blood Cancer 2004, 43, 398-398. 1.362 A38. Hevessy Z, Kiss F, Gyorfi-Veszpremi A, Haramura G, Katona E, Kiss C, Kappelmayer J: Aberrant immunophenotype - Expression of blood coagulation factor XIII in De Novo B-precursor acute lymphoblastic leukemia. Cytometry Part B-Clin Cytometry 67B: 35-35, 2005. 1.438 A39. Bereczky Z, Kiss C, Szabo T, Bardos H, Ajzner E, Balogh I, Komaromi L, Adany R, Muszbek L: Three novel missense mutations and their functional consequences in two severe inherited factor X deficiencies. Clin Chim Acta 355: S310-S311, 2005. 1.961 A40. Bardi E, Olah AV, Jenei C, Kappelmayer J, Kiss C: Acute tubular toxicity of cytostatic therapy in children with cancer. Nephrol Dial Transplant 20: V50-V51, 2005. 2.976 A41. Bardi E, Bodo T, Kiss C: Osteoporosis in children with cancer. Pediatr Nephrol 22: 1638-1638, 2007. 1.936 A42. Kiss F, Csathy L, Hevessy Z, Simon A, Katona E, Kiss C, Kappelmayer J: The cytoplasmic form of a coagulation factor becomes useful in the study of acute leukemias: Studies with factor XIII. Cytometry Part A 71A: 515-515. 2007. 2.978 A43. Kiss C, Kiss F, Hevessy Z, Katona E, Bardi E, Vereb G, Muszbek L, Kappelmayer J: Expression of coagulation factor XIII subunit a in leukemic lymphoblasts. Pediatr Blood Cancer 49: 442-442, 1 2007. 2.164 A44. Buslig J, Balogh M, Bardi E, Kiss C, Olah E, Scholtz B: Minimal residual disease in acute childhood leukemia. Blood Rev 21: S108-S109, 2007. 5.922 A45. Bessenyei B, Ujfalusi A, Balogh E, Kiss C, Bardi E, Szegedi I, Olah E: Jumping translocation of 1q in a case of childhood acute lymphoblastic leukemia, type L3 with t(8;14). Blood Rev 21: S110-S110, 2007. 5.922 A46. Ujfalusi A, Balogh E, Bessenyei B, Kiss C, Bardi E, Szegedi I, Olah E: Analysis of complex chromosome aberrations in childhood acute lymphoblastic leukemia (ALL) using multicolor fluorescent in situ hybridization (M-FISH). Blood Rev 21: S110-S110, 2007. 5.922 A47. Bardi E, Horkay E, Olah AV, Kappelmayer J, Kiss C: Protection of glomerular and tubular function by theophylline in children with cancer. Nephrol Dial Transplant 22: 103-103. 2007. 3.167
Citálható abstractok impakt faktora:
86.752
*Impakt faktor (IF) a 2007-ig megjelent közlemények esetében a folyóirat megjelenésének éve, illetőleg, korábbi évfolyamok esetében az IF kiszámításának első éve szerint (Oral Microbiology Immunology: 1990, Pathology Oncology Research: 2005, Pediatric Blood and Cancer: 2005).
A közleményekre tett független hivatkozások
308
Dr. Kiss Csongor lektorált folyóiratokban közölt cikkeire és citálható absztraktjaira történt szakirodalmi hivatkozások – 2009.01.19-i állapot, önidézettség nélkül. Idézett közlemény aláhúzva, a rá történt hivatkozások száma jobbra zárva (zárójelben), alatta a citáló közlemény(ek) specifikációi. Az ISI Science Citation Indexben nem regisztrált idéző közlemények dőlt karakterekkel szedve
Ad Tóth FD, Váczi L, Szabó B, Kiss J, Réthy A, Kiss A, Telek B, Kovács I, Kiss C, Rák K: Detection of main core proteins of simian type-C viruses and human retrovirus HTLV and antibodies to them in patients with lymphoid malignancies. Acta Microbiol Hung 32: 267-273, 1985. (2) Boller K, Janssen O, Schuldes H, Tonjes RR, Kurth, R: Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol 71:45814588, 1997. Bannert N, Kurth R: Retroelements and the human genome: New perspectives on an old relation. Proc Natl Acad Sci USA 101: 14572-14579, 2004.
Ad Ilyés I, Sári B, Kiss C, Jászberényi J: A glucose-tolerancia,az inzulin-rezisztencia és a lipoprotein-anyagcsere eltéréseinek összefüggése a gyermekkori kövérségben. Orvosi Hetil. 127: 2117-2121. 1986. (1) Acsai L, Petheő I: Gyermek- és serdülőkorú elhízott gondozottaink cardiovascularis rizikója. Orvosi Hetil 132: 2425-2430, 1991. Ad Morocz I, Benkő I, Bársony Z, Kiss C: Focal nodular hyperplasia of the liver in a young boy after clomiphene treatment. Acta Paediatr.Hung. 27: 15-21. 1986. (2) Reymond D, Aebi C, Hirt A, Leibundgut K, Plaschkes J, Luthy AR, Tschappeler H, Zimmermann A: Focal nodular hyperplasia of the liver in childhood. Med Pediatr Oncol 21: 283-286, 1993. Wolf R, Wolf D, Kuperman S: Focal nodular hyperplasia of the liver after itraconazole treatment. J Clin Gastroenterol 33:418-420, 2001. Ad Marton I, Harmati S, Kiss C: Immunologische Veranderungen bei patienten mit periapikalem Granulom. Z Stomatol 84:93-99, 1987. (1) Radics T: Gondolatok az apicalis Magyar Fogorvos 11:254-255, 2002.
periodontitis
korszerű
kezeléséről.
Ad Marton I, Kiss C, Balla G, Szabó T, Karmazsin L: Acute phase proteins in patients with chronic periapical granuloma before and after surgical treatment. Oral Microbiol Immunol 3:95-96. 1988. (5) Lerner UH: Regulation of bone metabolism by the kallikrein-kinin system, the coagulation cascade, and the acute-phase reactants. Oral Surg Oral Med Oral Pathol 78: 481-493, 1994. Tar I, Martos R: A fogágybetegségek és az általános szervi megbetegedések összefüggése. Fogorv Szle 95:73-77, 2002. Radics T: Gondolatok az apicalis Magyar Fogorvos 11:254-255, 2002.
periodontitis
korszerű
kezeléséről.
Caplan DJ: Epidemiologic issues in studies of association between apical periodontitis and systemic health. Endod Topics 8: 15-35, 2004. Caplan DJ, Chasen JB, Krall EA, Cai J, Kang S, Garcia RI, Offenbacher S, Beck JD: Lesions of endodontic origin and risk of coronary heart disease. J Dent Res 85: 996-1000, 2006. Ad Kiss C, Balázs M, Kovács I, Karmazsin L: Cell membrane fluidity in blast cells of children with various forms of acute leukaemia. Acta Paediatr. Hung. 30: 291-302. 1990. (1) Cezanne L, Gaboriau F, Charveron M, Tocanne JF, Dubertret L, Morliere P: Effects of the avene spring water on the dynamics of lipids in the membranes of cultured fibroblasts Skin Pharmacol 6: 231-240, 1993. Ad Kiss C, Balázs M, Keri-Fülöp I: Dexamethasone decreases membrane fluidity of leukemic cells. Leuk. Res. 14: 221-225. 1990. (11) Wilson KJ, Stillwell W, Maxam T, Baldridge T: Membrane fluidity changes in embryogenic and nonembryogenic cultures of asclepias and daucus in response to auxin removal. Physiol Plant 82: 633-639, 1991. Norgaard P, Poulsen HS: Glucocorticoid receptors in human malignancies - a review. Annal Oncol 2: 541-557, 1991. Marin L, Dufour ME, Nguyen TM, Tordet C, Garabedian M: Maturational changes induced by 1-alpha,25-dihydroxyvitamin-D(3) in type-II cells from fetal rat lung explants. Amer J Physiol 265: L45-L52, 1993. Szöllősi J: Mobility and proximity in biological membranes. (eds.: Damjanovich S et al.) CRC Press, Boca Raton, FL, pp. 137-209, 1994.
Elstein KH, Zucker RM: Comparison of cellular and nuclear-flow cytometric techniques for discriminating apoptotic subpopulations. Exp Cell Res 211: 322-331, 1994. Zucker RM, Elstein KH, Thomas DJ, Rogers JM: Tributyltin and dexamethasone induce apoptosis in rat thymocytes by mutually antagonistic mechanisms. Toxicol Appl Pharmacol 127: 163-170, 1994. Juneja HS, Harvey WH, Brasher WK, Thompson EB: Successful in vitro purging of leukemic blasts from marrow by cortivazol, a pyrazolosteroid - a preclinical study for autologous transplantation in acute lymphoblastic leukemia and non-Hodgkins lymphoma. Leukemia 9: 1771-1778, 1995. Levi M, Shayman JA, Abe A, Gross ,SK Mccluer RH, Biber J, Murer H, Lotscher M, Cronin RE, Scott SA, Wilson P: Dexamethasone modulates rat renal brush-border membrane phosphate transporter messenger-RNA and protein abundance and glycosphingolipid composition. J Clin Invest 96: 207-216, 1995. Zajicek H, Wang HM, Kumar V, Wilson P, Levi M: Role of glycosphingolipids in the regulation of renal phosphate transport. Kidney Internatl S61: S32-S35, 1997. Lackner C, Daufeldt S, Wildt L, Allera A: Glucocorticoid-recognizing and -effector sites in rat liver plasma membrane, kinetics of corticosterone uptake by isolated membrane vesicles. III. Specificity and stereospecificity. J Steroid Biochem Molec Biol 64: 69-82, 1998. Nambiar MP, Enyedi EJ, Fisher CU, Warke VG, Tsokos GC: High dose of dexamethasone upregulates TCR/CD3-induced calcium response independent of TCR zeta chain expression in human T lymphocytes. J Cell Biochem 83:401-413, 2001. Ad: Kiss C, Balázs M: Changes in leukemia cell membrane fluidity induced by growthrestrictive and permissive culture conditions. Leuk Res, 1990, 14, 293-294. (1) Szöllősi J: Mobility and proximity in biological membranes. (eds.: Damjanovich S et al.) CRC Press, Boca Raton, FL, pp. 137-209, 1994. Ad Kiss C.: Clonal growth and self-renewal of human myeloid leukemia cell lines (BRM and DD) in serum-free semi-solid medium. Blut 61: 317-319. 1990. (1) Keenan J, Dooley M, Pearson D, Clynes M: Recombinant human albumin in cell culture: Evaluation of growth-promoting potential for NRK and SCC-9 cells in vitro. Cytotechnology 24: 243-252, 1997. Ad Marton I, Kiss C, Szabó T: Akut-fázis fehérjék szerepe a kronikus periapikalis granuloma patogenezisében. Fogorvosi Szle 83: 235-239, 1990. (1) Buttke BM, Shipper G, Delano EO, Trope M: C-reactive protein and serum amyloid A
in a canine model of chronic apical periodontitis. J Endod 31: 728-732, 2005. Ad Kiss C, Kovács I, Karmazsin L: Decreased sensitivity to cytostatic drugs in glucocorticoid receptor-free AML cells. Clinical and experimental observations. Acta Pediatr Hung, 1991, 32, 223-231. (1) Styczynski J: Drug resistance in childhood acute myeloid leukemia. Current Pharmaceut Biotechnol 8: 59-75, 2007. Ad Marton I.J., Kiss C.: Influence of surgical treatment of periapical lesions on serum and blood levels of inflammatory mediators. Internatl.Endod.J. 25:229-233, 1992. (8) Moseley R, Waddington R, Evans P, Halliwell B, Embery G: The chemical modification of glycosaminoglycan structure by oxygen-derived species in vitro. BBA-Gen Subjects: 1244:245-252, 1995. Takahashi K: Microbiological, pathological, inflammatory, immunological and molecular biological aspects of periradicular disease Internatl Endod J 31:311-325, 1998. Tar I, Martos R: A fogágybetegségek és az általános szervi megbetegedések összefüggése. Fogorv Szle 95:73-77, 2002. Radics T: Gondolatok az apicalis Magyar Fogorvos 11:254-255, 2002.
periodontitis
korszerű
kezeléséről.
Caplan DJ: Epidemiologic issues in studies of association between apical periodontitis and systemic health. Endod Topics 8: 15-35, 2004. Buttke BM, Shipper G, Delano EO, Trope M: C-reactive protein and serum amyloid A in a canine model of chronic apical periodontitis. J Endod 31: 728-732, 2005. Wu MK, Dummer PMH, Wesselink PR: Consequences of and strategies to deal with residual post-treatment root canal infection. Internatl Endod J 39: 343-356, 2006. Caplan DJ, Chasen JB, Krall EA, Cai J, Kang S, Garcia RI, Offenbacher S, Beck JD: Lesions of endodontic origin and risk of coronary heart disease. J Dent Res 85: 996-1000, 2006. Ad Kiss C., Cesano A., Zsebő K.M., Clark S.C., Santoli D.: Human stem cell factor (c-kit ligand) induces an autocrine loop of growth in a GM-CSF-dependent megakaryocytic leukemia cell line. Leukemia 7: 235-240. 1993. (22) Auffray I, Dubart A, Izac B, Vainchenker W, Coulombel L: A murine stromal cell line promotes the proliferation of the human factor-dependent leukemic cell line Ut-7. Exp Hematol. 22: 417-425, 1994.
Lahm H, Wyniger J, Hertig S, Yilmaz A, Fischer JR, Givel JC, Odartchenko N: Secretion of bioactive granulocyte-macrophage colony-stimulating factor by human colorectal carcinoma cells. Cancer Res. 54: 3700-3702, 1994. Kees UR, Ashman LK: Synergistic action of interleukin-2 and steel factor (Slf) on a human T-lymphoblastoid cell line. Leukemia 9: 1046-1050, 1995. Li Y, Shen BF, Karanes C, Sensenbrenner L, Chen B: Association between Lyn proteintyrosine kinase (p53/56(Lyn)) and the beta-subunit of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human megakaryocytic leukemia cell line (M-07E). J Immunol 155: 2165-2174, 1995. Brizzi MF, Rossi PR, Rosso A, Avanzi GC, Pegoraro L: Transcriptional and posttranscriptional regulation of granulocyte-macrophage colony-stimulating factor production in human growth factor-dependent M-07E cells. Br J Haematol. 90: 258-265, 1995. Almeida J, Delcanizo C, Orfao A, Hernandez J, Hernandez D, Galende J, Caballero D, Garciasanz R, Sanmiguel JF: In vitro autonomous proliferation in ANLL - clinical and biological significance. Leuk Res 19: 411-416, 1995. Sasaki K, Ikeda K, Ogami K, Takahara J, Irino S: Cell-to-cell interaction of cytokinedependent myeloblastic line constitutively expressing membrane-bound stem cell factor abrogates cytokine dependency partially through granulocyte-macrophage colonystimulating factor production. Blood 85: 1220-1228, 1995. Lahm H, Amstad P, Yilmaz A, Borbenyi Z, Wyniger J, Fischer JR, Suardet L, Givel JC, Odartchenko N: Interleukin-4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells. Cell Growth and Diff 6: 1111-1118, 1995. Murohashi I, Endoh K, Feng M, Yoshida K, Hirota H, Yoshida S, Jinnai I, Bessho M , Hirashima K: Roles of stem cell factor in the in vitro growth of blast clonogenic cells from patients with acute myeloblastic leukemia. J Interferon Cytokine Res 15: 829-835, 1995. Akin C, Sonnenfeld G: Stimulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) production and its role as an autocrine inducer of CD14 upregulation in human myeloid leukemia cells. J Interferon Cytokine Res 16:479-486;1996. Gentry PC, Smith GW, Anthony RV, Zhang Z, Long DK, Smith MF: Characterization of ovine stem cell factor messenger ribonucleic acid and protein in the corpus luteum throughout the luteal phase. Biol. Reproduction 54:970-979, 1996. Sandrock B, Hudson KM, Williams DE, Lieberman MA: Cytokine production by a megakaryocytic cell line. In Vitro Cell Develop Biol-Animal 32:225-233, 1996.
Wadhwa M, Dilger P, Meager A, Walker B, GainesDas R, Thorpe R: IL-4 and TNFalpha-mediated proliferation of the human megakaryocytic line M-O7e is regulated by induced autocrine production of GM-CSF. Cytokine 8: 900-909, 1996. Sykora KW, Tomeczkowski J, Reiter A: C-kit receptors in childhood malignant lymphoblastic cells. Leuk. Lymphoma 25: 201-216, 1997. Caruana G, Cambareri AC, Gonda TJ, Ashman LK: Transformation of NIH3T3 fibroblasts by the c-Kit receptor tyrosine kinase: effect of receptor density and ligandrequirement. Oncogene 16: 179-190, 1998. Beghini A, Cairoli R, Morra E, Larizza L: In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent c-kit mutation. Blood Cell Molec Dis 24: 262-270, 1998. Grichnik JM, Burch JA, Burchette J, Shea CR: The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol 111: 233238, 1998. Tomeczkowski J, Frick D, Schwinzer B, Wittner N, Ludwig WD, Reiter A, Welte K, Sykora KW: Expression and regulation of c-kit receptor and response to stem cell factor in childhood malignant T-lymphoblastic cells. Leukemia 12: 1221-1229, 1998. Baatout S: Megakaryocytopoiesis: Growth factors, cell cycle and gene expression. Anticancer Res 18: 1871-1882, 1998. Dunn TA, Schmoll HJ, Rie C, Hartmann K, Casper J: Production and pre-clinical significance of haematopoietic peptide growth factors (HPGF) in human nonseminomatous germ cell tumour cell lines J. Cancer Res Clin Oncol.:435-443,1998. Caceres-Cortes JR, Krosl G, Tessier N, Hugo P, Hoang T: Steel factor sustains SCL expression and the survival of purified CD34(+) bone marrow cells in the absence of detectable cell differentiation. Stem Cells 19: 59-70; 2001. Lennartsson J, Shivakrupa R, Linnekin D: Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and independent contributions from c-Kit. J Biol Chem 279: 44544-44553, 2004.
Ad Kiss C.: Impaired capacity of multidrug resistance-related cytotoxic drugs to inhibit colony formation of dexamethasone-resistant human leukemic cell lines. Cancer Invest. 11: 358-360. 1993. (1) Bronnegard M, Stierna P, Marcus C: Glucocorticoid resistant syndromes - Molecular basis and clinical presentations. J Neuroendocrinol. 6: 405-415, 1996.
Ad Marton IJ, Kiss C: Characterization of inflammatory cell infiltrate in dental periapical lesions. Intenatl. Endod. J. 26: 131-136. 1993. (33) Okiji T: Class II MHC Molecule-expressing Cells of the Dental Pulp. Göteborg University Press, Göteborg, 1996. Kawashima N, Okiji T, Kosaka T, Suda H: Kinetics of macrophages and lymphoid cells during the development of experimentally induced periapical lesions in rat molars: A quantitative immunohistochemical study. J Endod 22:311-316, 1996. Nair PNR: Apical periodontitis: A dynamic encounter between root canalinfection and host response Periodontology 2000 13: 121-148, 1997. Delzangles B, BoyLefevre ML, Forest N: Glycoproteins expression in apical pathologic tissues: Clinical incidences. J Endod 23: 565-568, 1997. Llamas R, Segura JJ, JimenezRubio A, JimenezPlanas A: In vitro effect of parachlorophenol and camphorated parachlorophenol on macrophages J Endod 23: 728730, 1997. Segura JJ, Jimenez-Rubio A, Guerrero JM, Calvo JR, Feito JJ: Effect in vitro of Tifell (formocresol-eugenol) on macrophage adhesion. Internatl Endod J 31:112-116, 1998. Alavi AM, Gulabivala K, Speight PM: Quantitative analysis of lymphocytes and their subsets in periapical lesions. Internatl Endod J 31: 233-240,1998. Takahashi K: Microbiological, pathological, inflammatory, immunological and molecular biological aspects of periradicular disease Internatl Endod J 31:311-325, 1998. Stashenko P, Teles R, Dsouza R: Periapical inflammatory responses and their modulation. Critical Rev Oral Biol Med 9: 498-521, 1998. Sol MA, Tkaczuk J, Voigt JJ, Durand M, Sixou M, Maurette A, Thomsen M: Characterization of lymphocyte subpopulations in periapical lesions by flow cytometry Oral Microbiol Immunol 13: 253-258, 1998. Takahashi K, MacDonald DG, Murayama Y, Kinane DF: Cell synthesis, proliferation and apoptosis in human dental periapical lesions analysed by in situ hybridisation and immunohistochemistry Oral Dis 5: 313-320, 1999. Segura JJ, Jimenez-Rubio A, Guerrero JM, Calvo JR: Comparative effects of two endodontic irrigants, chlorhexidine digluconate and sodium hypochlorite, on macrophage adhesion to plastic surfaces J Endod 25: 243-246, 1999.
Suzuki N, Okiji T, Suda H: Enhanced expression of activation-associated molecules on macrophages of heterogeneous populations in expanding periapical lesions in rat molars. Arch Oral Biol 44: 67-79, 1999. Moreira PR, Santos DFM, Martins RD, Gomez RS: CD57(+) cells in radicular cyst. Internatl Endod J 33: 99-102, 2000. Fernando K, Gulabivala K, Barrett AW: The preparation of periapical lesions for flow cytometry Internatl Endod J 33: 103-112, 2000. Tasman F, Er N, Atac A, Dagdeviren A, Kendir B: CD45/isotypes expression in the immune cells of human periapical lesions J Endod 26: 166-168, 2000. Kaneko T, Okiji T, Kan L, Takagi M, Suda H: Ultrastructural analysis of MHC class II molecule-expressing cells in experimentally induced periapical lesions in the rat. J Endod 27:337-342, 2001. Nair PNR: Pathobiology of the Periapex. In: Cohen S, Burns RC (Eds): Pathways of the pulp. Mosby, St. Louis, MO, pp. 457-500, 2002. Tar I, Martos R: A fogágybetegségek és az általános szervi megbetegedések összefüggése. Fogorv Szle 95:73-77, 2002. Radics T: Gondolatok az apicalis Magyar Fogorvos 11:254-255, 2002.
periodontitis
korszerű
kezeléséről.
Liapatas S, Nakou M, Rontogianni D: Inflammatory infiltrate of chronic periradicular lesions: an immunohistochemical study. Int Endod J 36: 464-471, 2003. Slots J, Sabeti M, Simon JH: Herpesviruses in periapical pathosis: An etiopathogenic relationship? Oral Surg Oral Med O 96: 327-331, 2003. Rodini CD, Batista AC, Lara VS: Comparative immunohistochemical study of the presence of mast cells in apical granulomas and periapical cysts: Possible role of mast cells in the course of human periapical lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97: 59-63, 2004. Nair PNR: Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit Rev Oral Biol Med 15: 348-381, 2004. Ricucci D, Bergenholtz G: Histologic features of apical periodontitis in human biopsies. Endod Topics 8: 68-87, 2004. Leonardi R, Caltabiano R, Loreto C: Collagenase-3 (MMP-13) is expressed in periapical lesions: an immunohistochemical study. Internatl Endod J 38: 297-301, 2005.
Lukic A, Vasilijic S, Majstorovic I, Vucevic D, Mojsilovic S, Gazivoda D, Danilovic V, Petrovic R, Colic M: Characterization of antigen-presenting cells in human apical periodontitis lesions by flow cytometry and immunocytochemistry. Internatl Endod J 39: 626-636, 2006. Lukic A, Vojvodic D, Majstorovic I, Colic M: Production of interleukin-8 in vitro by mononuclear cells isolated from human periapical lesions. Oral Microbiol Immunol 21: 296-300, 2006. Caviedes-Bucheli J, Azuero-Holguin MM, Moreno GC, Gonzalez IL, Mateu E, Salazar JF, Munoz HR: Vasoactive intestinal peptide receptor expression in chronic periapical lesions. Internatl Endod J 40: 521-525, 2007. Wang L, Peng B: Correlation between platelet-derived growth factor B chain and bone resorption in rat periapical lesions. J Endod 33: 709-711, 2007. Andric M, Milasin J, Jovanovic T, Todorovic L: Human cytomegalovirus is present in odontogenic cysts. Oral Microbiol Immunol 22: 347-351, 2007. Saboia-Dantas CJ, de Toledo LFC, Siqueira JF, Sampaio-Filho HR, Carvalho JJ, Pereira MJS: Natural killer cells and alterations in collagen density: signs of periradicular herpesvirus infection? Clin Oral Invest 12: 129-135. 2008. Bolan M, Lima DD, Figueiredo CP, Di Giunta G, Rocha MJD: Immunohistochemical study of presence of T cells, B cells, and macrophages in periradicular lesions of primary teeth. J Clin Pediatr Dent 32: 287-293, 2008.
Ad Marton I.J., Balla G., Hegedűs C., Redl P., Szilágyi Z., Karmazsin L., Kiss C.: The role of reactive oxygen intermediates in the pathogenesis of chronic apical periodontitis. Oral Microbiol.Immunol. 8: 254-257. 1993. (17) Moseley R, Waddington RJ, Embery G: Degradation of glycosaminoglycans by reactive oxygen species-derived from stimulated polymorphonuclear leukocytes. Biochem Biophys Acta – Molec Basis Disease 1362: 221-231, 1997. Moseley R, Waddington RJ, Embery G, Rees SG: The modification of alveolar bone proteoglycans by reactive oxygen species in vitro Connective Tissue Res 37: 13-28, 1998. Battino M, Bullon P, Wilson M, Newman H: Oxidative injury and inflammatory periodontal diseases: The challenge of antioxidants to free radicals and reactive oxygen species. Crit Rev Oral Biol Med 10: 458-476, 1999.
Waddington RJ, Moseley R, Embery G: Periodontal disease mechanisms - Reactive oxygen species: a potential role in the pathogenesis of periodontal diseases. Oral Dis 6: 138-151, 2000. Tar I, Martos R: A fogágybetegségek és az általános szervi megbetegedések összefüggése. Fogorv Szle 95:73-77, 2002. Yeung SY, Lan WH, Huang CS, Lin CP, Chan CP, Chang MC, Jeng JH: Scavenging potential of three cresol isomers against H2O2, hypochlorite, superoxide and hydroxyl radicals. Food Chem Toxicol 40:1403-1413, 2002. Ritchie CS, Kinane DF: Nutrition, inflammation, and periodontal disease. Nutrition 19: 475-476, 2003. Kayaoglu G, Orstavik D: Virulence factors of Enterococcus faecalis: Relationship to endodontic disease. Crit Rev Oral Biol Med 15: 308-320, 2004. Akalin FA, Toklu E, Renda N: Analysis of superoxide dismutase activity levels in gingiva and gingival crevicular fluid in patients with chronic periodontitis and periodontally healthy controls. J Clin Periodontol 32: 238-243, 2005. Canakci CF, Cicek Y, Canakci V: Reactive oxygen species and human inflammatory periodontal diseases. Biochemistry-Moskow 70: 619-628, 2005. Tsai CC, Chen HS, Chen SL, Ho YP, Ho KY, Wu YM, Hung CC: Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res 40: 378-384, 2005. Celec P, Hodosy J, Celecova V, Vodrazka J, Cervenka T, Halcak L, Bozek P, Kopani M, Kudela M: Salivary thiobarbituric acid reacting substances and malondialdehyde - Their relationship to reported smoking and to parodontal status described by the papillary bleeding index. Disease Markers 21: 133-137, 2005. Akalin FA, Baltacioglu E, Alver A, Karabulut E: Lipid peroxidation levels and total oxidant status in serum, saliva and gingival crevicular fluid in patients with chronic periodontitis. J Clin Periodontol 34: 558-565, 2007. Yeung SY, Huang CS, Chan CP, Lin CP, Lin HN, Lee PH, Jia HW, Huang SK, Jeng JH, Chang MC: Antioxidant and pro-oxidant properties of chlorhexidine and its interaction with calcium hydroxide solutions. Internatl Endod J 40: 837-844, 2007. Akalin FA, Isiksal E, Baltacioglu E, Renda N, Karabulut E: Superoxide dismutase activity in gingiva in type-2 diabetes mellitus patients with chronic periodontitis. Arch Oral Biol 53: 44-52, 2008. Moynihan P: Update on nutrition and periodontal disease. Quintessence Internatl 39:
326-330. 2008. Khalili J, Biloklytska HF: Salivary malondialdehyde levels in clinically healthy and periodontal diseased individuals. Oral Dis 14: 754-760, 2008. Ad Kiss C, Surrey S, Schreiber AD, Schwartz E, McKenzie SE: Human c-kit ligand (stem cell factor) induces platelet Fc receptor expression in megakaryoblastic cells. Exp Hematol 24: 1232-1237. 1996. (4) MacLeod RAF, Dirks WG, Reid YA, Hay RJ, Drexler HG: Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting Leukemia 11: 2032-2038, 1997. Baatout S: Megakaryocytopoiesis: Growth factors, cell cycle and gene expression. Anticancer Res 18: 1871-1882, 1998. Tar I, Martos R: A fogágybetegségek és az általános szervi megbetegedések összefüggése. Fogorv Szle 95:73-77, 2002. Calverley DC, Brass E, Hacker MR, Tsao-Wei DD, Espina BM, Pullarkat VA, Hodis HN, Groshen S: Potential role of platelet Fc gamma RIIA in collagen-mediated platelet activation associated with atherothrombosis. Atherosclerosis 164: 261-267, 2002. Ad Pap Z, Ajzner É, Kiss C, Emődy J, Závodszky I, Horváth A, Muszbek L: Thrombocytafunkció-zavar albínó gyermekekben. Orvosi Hetil 138: 467-471. 1997. (1) Sutor AH: The bleeding time in pediatrics Semin Thromb Hemostasis 24:531-543, 1998. Ad Oláh É, Balogh E, Kajtár P, Pajor L, Jakab Z, Kiss C : Diagnostic and prognostic significance of chromosome abnormalities in childhood acute lymphoblastic leukemia (ALL). Annals of New York Acad. Sci. 824: 8-27, 1997. (11) Babusikova O, Sejnova D, Krischnerova G, Kirsnerova Z, Cap J: Correlation of clinical picture (event free survival and overall survival) in childhood acute leukemia patients with immunophenotype and chromosomal abnormalities. Neoplasma, 47: 382-389, 2000. Petridou E, Salkidou A, Dessypris N, Moustaki M, Mantzoros C, Spanos E, Trichopoulos D: Insulin-like growth factor binding protein-3 predicts survival from acute childhood leukemia. Oncology-Basel. 60: 252-257, 2001. Winter SS, Sweatman J, Shuster JJ, Link MP, Amylon MD, Pullen J, Camitta BM, Larson RS: Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemia cells predicts treatment outcome in children: a Pediatric Oncology Group study. Leukemia 16:1121-1126, 2002.
Takeuchi S, Tsukasaki K, Bartram CR, Seriu T, Zimmermann M, Schrappe M, Takeuchi N, Park S, Taguchi H, Koeffler HP: Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemia. Leukemia 17: 149-154, 2003. Thompson EB, Johnson BH: Regulation of distinctive sets in glucocorticoid-evoked apoptosis in CEM human lymphoid cells. Recent Progress in Hormone Res 58:175-197, 2003. Costea I, Moghrabi A, Krajinovic M: The influence of cyclin D1 (CCND1) 870A > G polymorphism and CCND1-thymidylate synthase (TS) gene - gene interaction on the outcome of childhood acute lymphoblastic leukaemia. Pharmacogenetics 13: 577-580, 2003. Wang S, Li N, Heald P, Fisk JM, Oluwole F, Howe JG, McNiff JM, Smith BR: Flow cytometric DNA ploidy analysis of peripheral blood from patients with Sezary syndrome - Detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue Am J Clin Pathol 122: 774-782, 2004. Sutcliffe MJ, Shuster JJ, Sather HN, Camitta BM, Pullen J, Schultz KR, Borowitz MJ, Gaynon PS, Carroll AJ, Heerema NA: High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI StandardRisk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative. Leukemia 19: 734-740, 2005. Wang XW, Li SB, Liu H, Mulvihill JJ, Chen W, Zheng B: A computer-aided method to expedite the evaluation of prognosis for childhood acute lymphoblastic leukemia. Technol Cancer Res Treatment 5: 429-436, 2006. Styczynski J, Kolodziej B, Rafinska B, Kubicka M, Czyewski K, Debski R, Kottan A, Kottan S, Pogorzala M, Krenska A, Palgan I, Dylewska K, Gaca A, Grzesk E, Tejza B, Jankowska K, Duleba K, Hagner A, Bartoszewicz N, Demidowicz E, RudzkaGockiewicz A, Szczepanek J, Kurylak A, Soszynska K, Mucha B, Haus O, Wysocki M: Combined in vitro drug resistance profile in childhood acute lymphoblastic leukemic on diagnosis and at relapse - relation to cell cycle and gene rearrangements. Wspotczesna Onkologia-Contemp Oncol 11: 367-375, 2007. Sharathkumar A, DeCamillo D, Bhambhani K, Cushing B, Thomas R , Mohamed AN, Ravindranath Y, Taub JW: Children with hyperdiploid but not triple trisomy (+4,+10,+17) acute lymphoblastic leukemia have an increased incidence of extramedullary relapse on current therapies: A single institution experience. Amer J Hemat 83:34-40, 2008.
Ad Marton IJ, Rot A, Radics T, Vályi-Nagy I, Kiss C: Expression of chemokine family of inflammatory cytokines in chronic apical periodontitis. 8 Bienn C Eur Soc E 13, 1997.
(1) Huang GTJ, Potente AP, Kim JW, Chugal N, Zhang XL: Increased interleukin-8 expression in inflamed human dental pulps. Oral Surg Oral Med Oral Pathol 88:214-220, 1999. Ad Balogh E., Swanton S, Kiss C, Jakab Z, Secker-Walker LM, Olah É: Fluorescnce in situ hybridization reveals trisomy 2q by insertion into 9p in hepatoblastoma. Cancer Genet Cytogenet 102: 148-150, 1998. (10) Nagata T, Mugishima H, Shichino H, Suzuki T, Chin M, Koshinaga S, Inoue M, Harada K: Karyotypic analyses of hepatoblastoma - Report of two cases and review of the literature suggesting chromosomal loci responsible for the pathogenesis of this disease. Cancer Genet Cytogenet 114: 42-50, 1999. Parada LA, Limon J, Iliszko M, Czauderna P, Gisselsson D, Hoglund M, Kullendorff CM, Wiebe T, Mertens F, Johansson B: Cytogenetics of hepatoblastoma: Further characterization of 1q rearrangements by fluorescence in situ hybridization – An international collaborative study. Med Pediatr Oncol 34: 165-170, 2000. Ma SK, Cheung ANY, Choy C, Chan GCF, Ha SY, Ching LM, Wan TSK, Chan LC: Cytogenetic characterization of childhood hepatoblastoma Cancer Genet Cytogenet 119: 32-36, 2000. Weber RG, Pietsch T, von Schweinitz D, Lichter P: Characterization of genomic alterations in hepatoblastomas – A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 157: 571-578, 2000. Gray SG, Kytola S, Matsunaga T, Larsson C, Ekstrom TJ: Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas Br J Cancer 83: 1020-1025, 2000. Buendia MA: Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. Med Pediatr Oncol 39: 530-535, 2002. Czepulkowski B, Saunders K, Pocock C, Sadullah S: Mosaic trisomy 2 in myelodysplastic syndromes and acute myeloblastic leukemias. Cancer Genet Cytogenet 145: 78-81, 2003 Nagata T, Nakamura M, Shichino H, Chin M, Sugito K, Ikeda T, Koshinaga T, Fukuzawa M, Inoue M, Mugishima H: Cytogenetic abnormalities in hepatoblastoma: report of two new cases and review of the literature suggesting imbalance of chromosomal regions on chromosomes 1, 4, and 12. Cancer Genet Cytogenet 156: 8-13, 2005. Tomlinson GE, Douglass EC, Pollock BH, Finegold MJ, Schneiders NR: Cytogenetic evaluation of a large series of hepatoblastomas: Numerical abnormalities with recurring
aberrations involving IqI2-q2I. Genes Chromosomes Cancer 44: 177-184, 2005. Suzuki M, Kato M, Yuyan C, Sanada M, Nannya Y, Yamamoto G, Takahashi A, Ikeda H, Kuwano H, Ogawa S, Hayashi Y: Whole-genome profiling of chromosomal aberrations in hepatoblastoma using high-density single-nucleotide polymorphism genotyping microarrays. Cancer Sci 99: 564-570, 2008.
Ad Marton IJ, Dezső B, Radics T, Kiss C: Distribution of interleukin-2 receptor α chain and class II antigen expressing cells in chronic human periapical lesions. Oral Microbiol Immunol 13:259-262. 1998. (4) Tar I, Martos R: A fogágybetegségek és az általános szervi megbetegedések összefüggése. Fogorv Szle 95:73-77, 2002. Hogan LH, Wang M, Suresh M, Co DO, Weinstock JV, Sandor M: CD4(+) TCR repertoire heterogeneity in Schistosoma mansoni-induced granulomas. J Immunol 169: 6386-6393, 2002. Han DC, Huang GTJ, Lin LM, Warner NA, Gim JS, Jewett A: Expression of MHC Class II, CD70, CD80, CD86 and pro-inflammatory cytokines is differentially regulated in oral epithelial cells following bacterial challenge. Oral Microbiol Immunol 18: 350-358, 2003. Tadokoro O, Radunovic V, Inoue K: Epithelial cell rests of malassez and OX6immunopositive cells in the periodontal ligament of rat molars: A light and transmission electron microscope study. Anat Record-Advances Integrative Aanat Evol Bbiol 291: 242-253, 2008.
Ad Marton I, Bagyi K, Radics T, Kiss C: Az apicalis periodontitis kialakulása és szervezetre gyakorolt hatása. Fogorv Szle 91:269-273, 1998. (1) Tar I, Martos R: A fogágybetegségek és az általános szervi megbetegedések összefüggése. Fogorv Szle 95:73-77, 2002. Ad Jakab Z, Balogh E, Kiss C, Pajor L, Oláh É: Biclonal chromosomal aberrations in a child with MDS. Cancer Genet Cytogenet 108: 13-18. 1999. (8) Kaiser Ll, Vizer M, Arany A, Veszprémi B: Correlation of prenatal clinicalfindings with those observed in fetal autopsies: pathological approach. Prenatal Diag. 20: 970-975, 2000. Hasle H.: Significance of monosomy 7 in myeloid leukemias in children. Pediatr Pathol Mol M 19: 235-250, 2000.
Acar H, Caliskan U, Kaynak M, Yildirim MS, Largaespada DA: Hyperdiploid karyotype in a childhood MDS patient. Clin Lab Haematol 23: 255-258, 2001. Farhi DC: Fluorescence DNA hybridization in the evaluation of clonal myeloid disease. J Clin Ligand Assay 24: 192-200, 2001. Han JY, Kim KH, Kwon HC, Kim JS, Kim HJ, Lee YH: Unrelated chromosome abnormalities in myelodysplastic syndromes and acute myeloid leukemias. Cancer Genet Cytogenet 132:156-158, 2002. Castagne C, Muhlematter D, Beyer V, Parlier V, van Melle G, Jotterand M: Determination of cutoff values to detect small aneuploid clones by interphase fluorescence in situ hybridization: the Poisson model is a more appropriate approach. Should single-cell trisomy 8 be considered a clonal defect? Cancer Genet Cytogenet 147: 99-109, 2003. Dolan M, Mascotti K: Cytogenetically unrelated clones in different histologic components of a Wilms tumor. Cancer Genet Ccytogenet 159: 63-68, 2005. Han JY, Theil KS, Hoeltge G: Frequencies and characterization of cytogenetically unrelated clones in various hematologic malignancies: seven years of experiences in a single institution. Cancer Genet Cytogenet 164: 128-132, 2006.
Ad Mikala G, Berencsi G, Kiss C, Márton I, Domján G, Vályi-Nagy I: Human herpesvirus 8 in hematologic diseases. Pathol Oncol Res 5:73-79; 1999. (8) Cummings TJ, Gong JZ, Friedman AH, McLendon RE: Castleman's disease confined to the leptomeninges. Ann Clin Lab Sci 30: 278-282, 2000. Burmeister T, Thiel E: Molecular genetics in acute and chronic leukemias. J Cancer Res Clin Oncol 127: 80-90, 2001. Sola P, Bedin R, Casoni F, Barozzi P, Mandrioli J, Merelli E: New insigths into the viral theory of amyotrophic lateral sclerosis: Study on the possible role of kaposi’s sarcomaassociated virus/human herpesvirus 8. Eur Neurol 47:108-112, 2002. de Sanjose S, Goedert JJ, Marshall V, Bellas C, Benavente Y, Bosch R, Domingo A, Fernandez A, de Sevilla AF, Servitje O, Whitby D: Risk of malignant lymphoma associated with human herpesvirus-8: a case-control study in Spain. Br J Cancer 90: 2145-2148, 2004. Deftereos S, Farmakis D, Papadogianni A, Besleme B, Diamanti-Kandarakis E, Polymeropoylos E, Georgonikou D, Aessopos A: Waldenstrom's macroglobulinemia developing in a patient with multiple sclerosis: coincidence or association? Multiple Sclerosis 10: 598-600, 2004.
Wang J, Bu DF, Li T, Zheng R, Zhang BX, Chen XX, Zhu XJ: Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus. Br J Dermatol 153: 558-564, 2005. Henke-Gendo C, Mengel M, Hoeper MM, Alkharsah K, Schulz TF: Absence of Kaposi's sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension. Amer J Resp Crit Care Med 172: 1581-1585, 2005 . Perdaens C, De Raeve H, Goossens A, Sennesael J: POEMS syndrome characterized by glomeruloid angioma, osteosclerosis and multicentric Castleman disease. J Eur Aacad Dermatol Venereol 20: 480-481, 2006.
Ad Kerenyi A, Schlammadinger A, Ajzner E, Szegedi I, Kiss C, Pap Z, Boda Z, Muszbek L: Comparison of PFA-100 closure time and template bleeding time in patients with inherited disorders causing defective platelet function. Thrombosis Res 96:487-492; 1999. (33) Favaloro EJ: Utility of the PFA-100 (R) for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations. Haemophilia 7: 170179, 2001. Favaloro EJ, Kershaw G, Bukuya M, Hertzberg M, Koutts J: Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA100 (R) and vWF : CBA as combined diagnostic strategies. Haemophilia 7: 180-189, 2001. Callan MB, Giger U: Assessment of a point-of-care instrument for identification of primary hemostatic disorders in dogs. Am J Vet Res 62: 652-658, 2001. Favaloro EJ: Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorde. Best Pract Res Cl Ha 14: 299-319, 2001. Jilma B: Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 138: 152-163, 2001. Konides PA: Menorrhagia from a haematologist’s point of view. Part I: initial evaluation. Haemophilia 8:330-338, 2002. Pieniaszek HJ, Sy SKB, Ebling W, Fossler MJ, Cain VA, Mondick JT, Kornhauser DM: Safety, tolerability, pharmacokinetics, and time course of pharmacologic response of the active metabolite of roxifiban, XV459, a glycoprotein IIb/IIIa antagonist, following oral administration in healthy volunteers. J Clin Pharmacol 47:738-753, 2002.
Buyukasik Y, Karakus S, Goker H, Hazendarglu H, Ozatli D, Sayinalp N, Ozcebe OI, Dundar SV, Kirazli S: Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Blood Coagulation Fibrinolysis 13:349353, 2002. Callan MB, Giger TJ: Effect of desmopressin acetate administration on primary hemostasis in Doberman Pintchers with type-1 von Willebrand diseaseas assessed by a point-of-care instrument. Am J Vet Res 63:1700-1706, 2002. Favaloro EJ: Clinical application of the PFA-100 ®. Curr Opin. Hematol. 9:407-415, 2002. Allen GA, Glader B: Approach to the bleeding child. Pediatr Clin North Am 49:1239-56, 2002. Cariappa R, Wilhite TR, Parvin CA, Luchtman-Jones L: Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems. J Pediatr Hematol Oncol 25: 474-479, 2003. Tarnow I, Kristensen AT, Texel H, Olsen LH, Pedersen HD: Decreased platelet function in Cavalier King Charles spaniels with mitral valve regurgitation.J Vet Intern Med 17: 680-686, 2003. Munsterhjelm E, Niemi TT, Syrjala MT, Ylikorkala O, Rosenberg PH: Propacetamol augments inhibition of platelet function by diclofenac in volunteers. Br J Anaesth 91: 357-36 , 2003. Posan E, McBane RD, Grill DE, Motsko CL, Nichols WL: Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thrombosis Haemost 90: 483-490, 2003. Fricke W, Kouides P, Kessler C, Schmaier AH, Krijanovski Y, Jagadeesan K, Joist J: A multicenter clinical evaluation of the Clot Signature Analyzer. J Thromb Haemost 2: 763768, 2004. Koscielny J, von Tempelhoff GF, Ziemer S, Radtke H, Schmutzler M, Sinha P, Salama A, Kiesewetter H, Latza R: A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thrombosis-Hemost 10: 155-166, 2004. Quiroga T, Goycoolea M, Munoz B, Morales M, Aranda E, Panes O, Pereira J, Mezzano D: Template bleeding time and PFA-100 (R) have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J Thromb Haemost 2: 892-898, 2004. Harrison P: The role of PFA-100((R)) testing in the investigation and management of
haemostatic defects in children and adults. Br J Haematol 130: 3-10, 2005. Munsterhjelm E, Niemi TT, Ylikorkala O, Silvanto M, Rosenberg PH: Characterization of inhibition of platelet function by paracetamol and its interaction with diclofenac in vitro. Ata Anaesth Scand 49: 840-846, 2005. Franchini M: The platelet-function analyzer (PFA-100 (R)) for evaluating primary hemostasis. Hematology 10: 177-181, 2005. Segura D, Monreal L, Espada Y, Pastor J, Mayos I, Homedes J: Assessment of a platelet function analyser in horses: Reference range and influence of a platelet aggregation inhibitor. Veter J 170: 108-112, 2005. Franchini M: The platelet function analyzer (PFA-100 (R)): an update on its clinical use. Clin Lab 51: 367-372, 2005. Harrison P, Mackie I, Mathur A, Robinson MSC, Hong Y, Erusalimsky JD, Machin SJ, Martin JF: Platelet hyper-function in acute coronary syndromes. Blood Coag Fibrinolysis 16: 557-562, 2005. Hayward CPM, Harrison P, Cattaneo M, Ortel TL, Rao AK, Platelet Physiology Subcomm Sci St: Platelet function analyzer (PFA)-100 (R) closure time in the evaluation of platelet disorders and platelet function. J Thrombosis Haemostasis 4: 312-319, 2006. Webb JA, Allen DG, Abrains-Ogg ACG, Gentry PA: Effects of doxycycline, amoxicllin, cephalexin, and enrofloxacin on hemostatis in healthy dogs. Amer J Vet Res 67: 569-576, 2006. Favaloro EJ: The utility of the PFA-100 in the identification of von Willebrand disease: A concise review. Semin Thromb Hemost 32: 537-545, 2006. Favaloro EJ: Laboratory monitoring of therapy in von Willebrand disease: Efficacy of the PFA-100 and von Willebrand factor: Collagen-binding activity as coupled strategies. Semin Tthromb Hemost 32: 566-576, 2006. Karger R, Donner-Banzhoff N, Muller HH, Kretschmer V, Hunink M: Diagnostic performance of the platelet function analyzer (PFA-100 (R)) for the detection of disorders of primary haemostasis in patients with a bleeding history - a systematic review and meta-analysis. Platelets 18: 249-260, 2007. Podda GM, Bucciarelli P, Lussana F, Lecchi A, Cattaneo M: Usefulness of PFA-100 (R) testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time. J Thromb Haemost 5: 2393-2398, 2007. Ballas M, Kraut EH: Bleeding and bruising: A diagnostic work-up. Amer Fam Physician 77: 1117-1124.
Masliah-Planchon J, Flaujac C, Tapon-Bretaudiere J, Cramer-Borde EM, Darnige L: Review: delta-storage pool disease. Ann Biol Clinique 66: 365-369, 2008. Pereira J, Quiroga T, Mezzano D: Laboratory assessment of familial, nonthrombocytopenic bleeding: A definitive not possible mucocutaneous diagnosis is often not possible. Semin Thromb Hemost 34: 654-662, 2008. Ad Marton IJ, Rot A, Schwartzinger E, Szakáll S, Radics T, Vályi-Nagy I, Kiss C: Differential in situ distribution of interleukin-8, macrophage chemoattractant protein-1 and Rantes in human chronic periapical granuloma. Oral Microbiol Immunol 15: 63-65, 2000. (8) Tar I, Martos R: A fogágybetegségek és az általános szervi megbetegedések összefüggése. Fogorv Szle 95:73-77, 2002. Mizgerd JP: Molecular mechanisms of neutrophil recruitment elicited by bacteria in the lungs. Semin Immunol 14:123-132, 2002. Haroune N, Combourieu B, Besse P, Sancelme M, Reemtsma T, Kloepfer A, Diab A, Knapp JS, Baumberg S, Delort AM: Benzothiazole degradation by Rhodococcus pyridinovorans strain PA: Evidence of a catechol 1,2-dioxygenase activity. Appl Environ Microbiol 68: 6114-6120, 2002. Komoda T, Yoshida K, Abe N, Sugiyama Y, Imachi M, Hirota H, Koshino H, Hirota A: Tetrapetalone A, a novel lipoxygense inhibitor from Streptomyces sp. Biosci Biotech Biochem 68: 104-111, 2004. Silva TA, Garlet GP, Lara VS, Martins W, Silva JS, Cunha FQ: Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases. Oral Microbiol Immunol 20: 310-316, 2005. Lukic A, Vojvodic D, Majstorovic I, Colic M: Production of interleukin-8 in vitro by mononuclear cells isolated from human periapical lesions. Oral Microbiol Immunol 21: 296-300, 2006. Fukushi E: Advanced NMR approaches for a detailed structure analysis of natural products. Biosci Biotechnol Biochem 70: 1803-1812, 2006. Takeichi O, Hama S, Iwata K, Ito K: Confocal immunolocalization of VE-cadherin- and CXC chemokine-expressing endothelial cells in periapical granulomas. Internatl Endod J 41: 401-407, 2008.
Ad Kiss C, Mészner Z: Gyermekkori lázas neutropeniás epizódok empirikus aniinfektív gyógykezelése. Gyermekgyógy 51: 112-121, 2000. (1)
Muller J, Garami M, Constantin T, Schmidt M, Fekete G, Kovacs G: Meropenem in the treatment of febrile neutropenic children. Pediatr Hematol Oncol 22: 277-284, 2005.
Ad Marton IJ, Kiss C: Protective and destructive immune reactions in apical periodontitis. Oral Microbiol Immunol 15:139-150; 2000. (34) Rodini CD, Lara VS: Study of the expression of CD68(+) macrophages and CD8(+) T cells in human granulomas and periapical cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:221-227, 2001. Kabashima H, Nagata K, Maeda K, Iijima T: Involvement of substance P, mast cells, TNF-alpha and ICAM-1 in the infiltration of inflammatory cells in human periapical granulomas. J Oral Pathol Med 31:175-180, 2002. Tar I, Martos R: A fogágybetegségek és az általános szervi megbetegedések összefüggése. Fogorv Szle 95:73-77, 2002. Nickolaychuk B, McNicol A, Gilchrist J, Birek C: Evidence for a role of mitogenactivated protein kinases in proliferating odontogenic epithelia of inflammatory and developmental cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:720-729, 2002. Puliti M, von Hunolstein C, Bistoni F, Castronari R, Orefici G, Tissi L: Role of macrophages in experimental group B streptococcal arthritis. Cell Microbiol 4: 691-699, 2002. Radics T: Gondolatok az apicalis Magyar Fogorvos 11:254-255, 2002.
periodontitis
korszerű
kezeléséről.
Sabeti M, Valles Y, Nowzari H, Simon JH, Kermani-Arab V, Slots J: Cytomegalovirus and Epstein-Barr virus DNA transcription in endodontic symptomatic lesions. Oral Microbiol Immunol 18: 104-108, 2003. Sabeti M, Simon JH, Slots J: Cytomegalovirus and Epstein-Barr virus are associated with symptomatic periapical pathosis. Oral Microbiol Immunol 18: 327-328, 2003. Sabeti M, Simon JH, Nowzari H, Slots J: Cytomegalovirus and Epstein-Barr virus active infection in periapical lesions of teeth with ions intact crowns. J Endod 29:321-323, 2003. Jacinto RC, Gomes BPFA, Ferraz CCR, Zaia AA, Souzafilho FJ.: Microbiological analysis of infected root canals from symptomatic and asymptomatic teeth with periapical periodontitis and the antimicrobial susceptibility of some isolated anaerobic bacteria. Oral Microbiol Immun 18: 285-292, 2003. Sabeti M, Simon JH, Slots J: Cytomegalovirus and Epstein-Barr virus are associated with
symptomatic periapical pathosis. Oral Microbiol Immun 18: 327-328, 2003. Slots J, Sabeti M, Simon JH: Herpesviruses in periapical pathosis: An etiopathogenic relationship? Oral Surg Oral Med O 96:327-331, 2003. Happonen RP, Bergenholtz G: Apical periodontitis. In: Bergenholtz G, Horsted-Bindlev P, Reit C (eds.): Textbook of Endodontology. Blackwell Publ. Ltd., Oxford, 2003, pp. 130144 Rotstein I, Simon JHS: Diagnosis, prognosis and decision-making in the treatment of combined periodontal-endodontic lesions. Periodontology 2000 34: 165-203, 2004. Slots J, Nowzari H, Sabeti M: Cytomegalovirus infection in symptomatic periapical pathosis. Internatl Endod J 37: 519-524, 2004. Kawahara T, Murakami S, Noiri Y, Ehara A, Takemura N, Furukawa S, Ebisu S: Effects of cyclosporin-A-induced immunosuppression on periapical lesions in rats. J Dental Res 83: 683-687, 2004. Asfora KK, Santos MDMD, Montes MAJR, Machado CM, de Castro B: Evaluation of biocompatibility of sodium perborate and 30% hydrogen peroxide using the analysis of the adherence capacity and morphology of macrophages. J Dentistry 33: 155-162, 2005. Kabak SL, Kabak YS, Anischenko SL: Light microscopic study of periapical lesions associated with asymptomatic apical periodontitis. Annals Anat-Anatomischer Anzeiger 187: 185-194, 2005. Quesnell BT, Alves M, Hawkinson RW, Johnson BR, Wenckus CS, BeGole EA: The effect of human immunodeficiency virus on endodontic treatment outcome. J Endod 31: 633-636, 2005. Yamasaki M, Morimoto T, Tsuji M, Akihiro I, Maekawa Y, Nakamura H: Role of IL-2 and helper T-lymphocytes in limiting periapical pathosis. J Endod 32: 24-29, 2006. Vernal R, Dezerega A, Dutzan N, Chaparro A, Leon R, Chandia S, Silva A, Gamonal J: RANKL in human periapical granuloma: possible involvement in periapical bone destruction. Oral Dis 12: 283-289, 2006. Slots J, Saygun I, Sabeti M, Kubar A: Epstein-Barr virus in oral diseases.J Periodontal Res 41: 235-244, 2006. Lukic A, Vasilijic S, Majstorovic I, Vucevic D, Mojsilovic S, Gazivoda D, Danilovic V, Petrovic R, Colic M: Characterization of antigen-presenting cells in human apical periodontitis lesions by flow cytometry and immunocytochemistry. Internatl Endod J 39: 626-636, 2006.
Menezes R, Bramante CM, Paiva KBD, Letra A, Carneiro E, Zambuzzi WF, Granjeiro JM: Receptor activator NF kappa B-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102: 404-409, 2006. Colic M, Lukic A, Vucevic D, Milosavljevic P, Majstorovic I, Marjanovic M, Dimitrijevic J: Correlation between phenotypic characteristics of mononuclear cells isolated from human periapical lesions and their in vitro production of Th1 and Th2 cytokines. Arch Oral Biol 51: 1120-1130, 2006. Huth KC, Saugel B, Jakob FM, Cappello C, Quirling M, Paschos E, Ern K, Hickel R, Brand K: Effect of aqueous ozone on the NF-kappa B system. J Dent Res 86: 451-456, 2007. Rezende TMB, Vieira LQ, Cardoso FP, Oliveira RR, de Oliveira Mendes ST, Jorge MLR, Ribeiro AP: The effect of mineral trioxide aggregate on phagocytic activity and production of reactive oxygen, nitrogen species and arginase activity by M1 and M2 macrophages. Int Endod J 40: 603-611, 2007. Andric M, Milasin J, Jovanovic T, Todorovic L: Human cytomegalovirus is present in odontogenic cysts. Oral Microbiol Immunol 22: 347-351, 2007. Saboia-Dantas CJ, de Toledo LFC, Sampaio-Filho HR, Siqueira JF: Herpesviruses in asymptomatic apical periodontitis lesions: an immunohistochemical approach. Oral Microbiol Immunol 22: 320-325, 2007. Martinez ZRA, Naruishi K, Yamashiro K, Myokai F, Yamada T, Matsuura K, Namba N, Arai H, Sasaki J, Abiko Y, Takashiba S: Gene profiles during root canal treatment in experimental rat periapical lesions. J Endod 33: 936-943, 2007. Takeichi O, Hama S, Iwata K, Ito K: Confocal immunolocalization of VE-cadherin- and CXC chemokine-expressing endothelial cells in periapical granulomas. Internatl Endod J 41: 401-407, 2008. Lukic A, Danilovic V, Petrovic R: Comparative immunohistochemical and quantitative analysis of inflammatory cells in symptomatic and asymptomatic chronic periapical lesions. Vojnosanitetski Pregled 65: 435-440, 2008. Yazdi KA, Sabeti M, Jabalameli F, Eini ME, Kolahdouzan SA, Slots J: Relationship between human cytomegalovirus transcription and symptomatic apical periodontitis in Iran. Oral Microbiol Immunol 23: 510-514, 2008. Carneiro E, Menezes R, Garlet GP, Garcia RB, Bramante CM, Figueira R, Sogayar M, Granjeiro JM: Expression analysis of matrix metalloproteinase-9 in epithelialized and nonepithelialized apical periodontitis lesions. Oral Surg Oral Med Orel Pathol Oral Radiol Endod 107: 127-132, 2009.
Ad Benkő I, Kovács P, Szegedi I, Megyeri A, Kiss A, Balogh E, Olah E, Kappelmayer J, Kiss C: Effect of myelotropic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia. N-S Arch Pharnmacol, 2001, 363, 499-508. (1) Sasse EC, Sasse AD, Brandalise SR, Clark OAC, Richards S: Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia. Cochrane Database of systematic reviews (3): Art. No. CD004139.pub2, 2005. Ad Kappelmayer J, Kiss A, Karászi É, Jakó J, Kiss C : Identification of P-selectin glycoprotein ligand-1 as a useful marker in acute myeloid leukaemias. Br J Haematol, 2001, 115, 903-909. (6) Marsik C, Mayr F, Cardona F, Schaller G, Wagner OF, Jilma B: Endotoxin downmodulates P-selectin glycoprotein ligand-1 (PSGL-1, CD162) on neutrophils in humans. J Clin Immunol 24: 62-65, 2004. Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W: Adult acute myeloid leukaemia. Crit Rev Oncol Hemat 50: 197-221, 2004. Ahn KC, Jun AJ, Pawar P, Jadhav S, Napier S, McCarty OJT, Konstantopoulos K: Preferential binding of platelets to monocytes over neutrophils under flow. Biochem Biophys Res Comm 329: 345-355, 2005. Schumacher A: Effect of ex vivo storage and Cyto-Chex on the expression of P-selectin glycoprotein ligand-1 (PSGL-1) on human peripheral leukocytes. J Immunol Methods 323: 24-30, 2007. Janic D, Jovanovic N, Dokmanovic L, Brasanac D, Smoljanic Z, Lazic J, Rodic P: Myeloid sarcoma presenting with bilateral proptosis and kidney infiltration. Pediatr Hematol Oncol 24: 141-148, 2007. Izzi B, Pampuch A, Costanzo S, Vohnout B, Iacoviello L, Cerletti C, de Gaetano G: Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood. Thromb Haemost 98: 1276-1284, 2007. Ad Redl P, Gyulahazi J, Kiss C, Marton I: Fibromatosis in the paramandibular region. Med Pediatr Oncol, 2001, 37, 75-76. (1) Lackner H, Urban C, Benesch M, Raith J, Moser A, Sovinz P, Schwinger W, Dornbusch HJ, Triebl-Roth K: Multimodal treatment of children with unresectable or recurrent desmoid tumors: An 11-year longitudinal observational study. J Pediatr Hematol Oncol 26: 518-522, 2004.
Ad Kiss C, Kiss M, Szegedi I, Árvai K, Tóth J, Oláh E: Interferon-alpha therapy in children with malignant diseases: clinical experiences in 24 patients treated in a single pediatric oncology unit. Med Pediatr Oncol 39:115-119, 2002. (6) Brown RE: Interferon-alpha therapy, protein kinase C-alpha and langerhans cell histiocytosis. Med Pediatr Oncol 41: 63-64, 2003. Ismail-Zade RS, Zhavrid EA, Potapnev MP: Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma. Pediatr Blood Cancer 44: 679-681, 2005. Hicks J, Flaitz CM: Langerhans cell histiocytosis: Current insights in a molecular age with emphasis on clinical oral and maxillofacial pathology practice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100: S42-S66, 2005. Quesada AR, Munoz-Chapuli R, Medina MA: Anti-angiogenic drugs: from bench to clinical trials. Med Res Rev 26: 483-530, 2006. Allen CE, McClain KL: Langerhans cell histiocytosis: A review of past, current and future therapies . Drugs of Today 43: 627-643, 2007. Mauriz JL, Gonzalez-Gallego J: Antiangiogenic drugs: Current knowledge and new approaches to cancer therapy. J Pharmaceut Sci 97: 4129-4154, 2008. Ad Jakab Z, Szegedi I, Balogh E, Kiss C, Oláh E: Duchenne muscular dystrophyrhabdomyosarcoma, ichthyosis vulgaris-acute monoblastic leukemia: association of rare genetic disorders and childhood malignant diseases. Med Pediatr Oncol 39: 66-68, 2002. (3) Mehes K, Kosztolanyi G: Clinical manifestations of genetic instability overlap one another. Pathol Oncol Res 10: 12-16, 2004. Doddihal H, Jalali R: Medulloblastoma in a child with Duchenne muscular dystrophy. Childs Nervous System 23: 595-597, 2007. Chamberlain J, Metzger JS, Reyes M, Townsend DW, Faulkner JA: Dystrophindeficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J 21: 2195-2204, 2007.
Ad Jakab Z, Balogh E, Kiss C, Olah E: Epidemiologic studies in a population based childhood cancer registry in North-East Hungary. Med Pediatr Oncol, 2002, 38, 338-344. (4)
McNally RJQ, Eden TOB: An infectious aetiology for childhood acute leukaemia: a review of the evidence. Br J Haematol 127: 243-263, 2004. Millot F, Traore P, Guilhot J, Nelken B, Leblanc T, Leverger G, Plantaz D, Bertrand Y, Bordigoni P, Guilhot F: Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia. Pediatr 116: 140-143, 2005. Nyari TA, Kajtar P, Parker L: Neuroblastoma in Hungary. Eur J Cancer 42: 2350-2354, 2006. Nyari TA, Kajtar P, Bartyik K, Thurzo L, Parker L: Childhood acute lymphoblastic leukaemia in relation to population mixing around the time of birth in south Hungary. Pediatr Blood Cancer 47: 944-948, 2006.
Ad Radics T, Kiss C, Tar I, Marton IJ: Interleukin-6 and GM-CSF in apical periodontitis: correlation with clinical and histologic findings of the involved teeth. Oral Microbiol Immunol 18: 9-13, 2003. (5) Slots J, Sabeti M, Simon JH: Herpesviruses in periapical pathosis: An etiopathogenic relationship? Oral Surg Oral Med O 96:327-331, 2003. Slots J, Nowzari H, Sabeti M: Cytomegalovirus infection in symptomatic periapical pathosis. Internatl Endod J 37: 519-524, 2004. Vernal R, Dezerega A, Dutzan N, Chaparro A, Leon R, Chandia S, Silva A, Gamonal J: RANKL in human periapical granuloma: possible involvement in periapical bone destruction. Oral Dis 12: 283-289, 2006. Prso IB, Kocjan W, Simic H, Brumini G, Pezelj-Ribaric S, Borcic J, Ferreri S, Karlovic IM: Tumor necrosis factor-alpha and interleukin 6 in human periapical lesions. Mediators of inflammation Art. No. 38210 2007 Bolan M, Lima DD, Figueiredo CP, Di Giunta G, Rocha MJD: Immunohistochemical study of presence of T cells, B cells, and macrophages in periradicular lesions of primary teeth. J Clin Pediatr Dent 32: 287-293, 2008.
Ad Győrfy A, Kovács T, Szegedi I, Oláh E, Kiss C: Sweet syndrome associated with 13-cisretinoic acid (isotretinoin) therapy. Med Pediatr Oncol 40: 135-136, 2003. (6) Al-Saad K, Khanani MF, Naqvi A, Krafchik B, Grant R, Pappo A: Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia. J Pediatr Hematol Oncol l26: 197-199, 2004.
Ammar D, Denguezli M, Ghariani N, Sriha B, Belajouza C, Nouira R: Sweet's syndrome complicating isotretinoin therapy in acne. Annales Dermatol Venereol 134: 151-154, 2007. Thompson DF, Montarella KE: Drug-induced Sweet's syndrome. Ann Pharmacother 41: 802-811, 2007. Cohen PR: Sweet's syndrome - a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2 Article Number: 34, 2007. Buck T, Gonzalez LM, Lambert WC, Schwartz RA: Sweet's syndrome with hematologic disorders: a review and reappraisal. Internatl J Dermatol 47: 775-782, 2008. Hospach T, von den Driesch P, Dannecker GE: Acute febrile neutrophilic dermatosis (Sweet's syndrome) in childhood and adolescence: two new patients and review of the literature on associated diseases. Eur J Pediatr 168:1-9, 2008. Ad. Szántó J, András C, Tsakiris J, Gomba S, Szentirmay Z, Bánlaki S, Szilágyi I, Kiss C, Antall P, Horváth A, Lengyel L, Castiglione-Gertsch M: Secretory breast cancer in a 7.5year old boy. Breast 13: 439-442, 2004. (4) Donovan T, Flynn M: What makes a man a man? The lived experience of male breast cancer. Cancer Nursing 30: 464-470, 2007. Kayton ML, Delgado R, Busam K, Cody HS, Athanasian EA, Coit D, La Quaglia MP: Experience with 31 sentinel lymph node biopsies for sarcomas and carcinomas in pediatric patients. Cancer 112: 2052-2059, 2008. Gutierrez JC, Housri N, Koniaris LG, Fischer AC, Sola JE: Malignant breast cancer in children: A review of 75 patients. J Surg Res 147: 182-188, 2008. Mun SH, Ko EY, Han BK, Shin JH, Kim SJ, Cho EY: Secretory carcinoma of the breast Sonographic features. J Ultrasound Med 27: 947-954, 2008. Ad Kiss C, Benkő I, Kovács P: Leukemic cells and the cytokine patchwork. Pediatr Blood Cancer 42: 113-121, 2004. (4) Marton IJ: How does the periapical inflammatory process compromise general heath? Endod Topics 8: 3-14, 2004. Balog A, Borbenyi Z, Gyulai Z, Molnar L, Mandi Y: Clinical importance of transforming growth factor-beta but not of tumor necrosis factor-alpha gene polymorphisms in patients with the myelodysplastic syndrome belonging to the refractory anemia subtype. Pathobiology 72: 165-170, 2005.
Leung KN, Mak NK, Fung MC: Cytokines in the differentiation therapy of leukemia: From laboratory investigations to clinical applications. Crit Rev Clin Lab Sci 42: 473-514, 2005. Avramis IA, Panosyan EH, Dorey F, Holcenberg JS, Avramis VI: Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: A report from Children's Oncology Group study CCG-1962. Clin Cancer Res 12: 6978-6984, 2006. Ad Bárdi E, Bobok I, Oláh VA, Oláh É, Kappelmayer J, Kiss C: Cystatin C is a suitable marker of glomerular function in children with cancer. Pediatr Nephrol 19:1145-1147, 2004. (12) Krawczuk-Rybak M, Kuzmicz M, Wysocka J: Renal function during and after treatment for acute lymphoblastic leukemia in children. Pediatr Nephrol 20: 782-785, 2005. Pavicevic S, Peco-Antic A: Cystatin C: our experience. Pediatr Nephrol 20: 842-843, 2005. Chen N, Aleksa K, Woodland C, Rieder M, Koren G: Ontogeny of drug elimination by the human kidney. Pediatr Nephrol 21: 160-168, 2006. Seronie-Vivien S, Toullec S, Malard L, Thomas F, Durrand V, Chatelut E: Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patients. Med Oncol 23: 63-73, 2006. Benohr P, Grenz A, Hartmann JT, Muller GA, Blaschke S: Cystatin C - A marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy. Kidney Blood Pressure Res 29: 32-35, 2006. Treiber M, Balon BP, Gorenjak M: Cystatin C versus creatinine as a marker of glomerular filtration rate in the newborn. Wiener Kli Wo 118: 66-70 (Suppl. 2), 2006. Mitsnefes M, Kimbal T, Kartal J, Kathman T, Mishra J, Devarajan P: Serum cystatin C and left ventricular diastolic dysfunction in children with chronic kidney. Pediatr Nephrol 21: 1293-1298, 2006. Caravaca F: Cystatin C: Yes, but ... Nefrologia 26: 421-425, 2006. Mitsnefes MM, Kathman TS, Mishra J, Kartal J, Khoury PR, Nickolas TL, Barasch J, Devarajan P: Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 22: 101-108, 2007. Zaffanello M, Franchini M, Fanos V: Is serum cystatin-C a suitable marker of renal function in children? Ann Clin Lab Sci 37: 233-240, 2007.
Gronroos MH, Jahnukainen T, Irjala K, Harkanen R, Hurme S, Mottonen M, Salmi TT: Comparison of glomerular function tests in children with cancer. Pediatr Nephrol 23: 797803, 2008. Ullmann AJ: Nephrotoxicity in the setting of invasive fungal diseases. Mycoses 51: 2530, 2008.
Ad Bárdi E, Oláh VA, Bartyik K, Endreffy E, Jenei C, Kappelmayer J, Kiss C: Late effects on renal glomerular and tubular function in childhood cancer survivors. Pediatr Blood Cancer 43: 668-673, 2004. (6) Lankisch P, Wessalowski R, Maisonneuve P, Haghgu M, Hermsen D, Kramm CM: Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age. Pediatr Blood Cancer 46:767-772, 2006. Zheng ZY, Pavlidis P, Chua S, D'Agati VD, Gharavi AG: An ancestral haplotype defines susceptibility to doxorubicin nephropathy in the laboratory mouse. J Amer Soc Nephrol 17: 1796-1800, 2006. Dickerman JD: The late effects of childhood cancer therapy. Pediatr 119: 554-568, 2007. Kaya Z, Gursel T, Bakkaloglu SA, Kocak U, Atasever T, Oktar SO: Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol 24: 257-267, 2007. Zaffanello M, Franchini M, Fanos V: Is serum cystatin-C a suitable marker of renal function in children? Ann Clin Lab Sci 37: 233-240, 2007. Gronroos MH, Jahnukainen T, Mottonen M, Perkkio M, Irjala K, Salmi TT: Long-term follow-up of renal function after high-dose methotrexate treatment in children. Pediatr Blood & Cancer 51: 535-539, 2008.
Ad Kiss C: Cell-to-cell interactions. Endod Topics 8: 88-103, 2004.
(2)
Colic M, Lukic A, Vucevic D, Milosavljevic P, Majstorovic I, Marjanovic M, Dimitrijevic J: Correlation between phenotypic characteristics of mononuclear cells isolated from human periapical lesions and their in vitro production of Th1 and Th2 cytokines. Arch Oral Biol 51: 1120-1130, 2006. Lukic A, Danilovic V, Petrovic R: Comparative immunohistochemical and quantitative
analysis of inflammatory cells in symptomatic and asymptomatic chronic periapical lesions. Vojnosanitetski Pregled 65: 435-440, 2008. Ad Alberth M, Kovalecz G, Nemes J, Math J, Kiss C, Marton IJ: Oral health of long-term childhood cancer survivors. Pediatr Blood Cancer 2004, 43, 88-90. (4) Dickerman JD: The late effects of childhood cancer therapy. Pediatr 119: 554-568, 2007. Avsar A, Elli M, Darka O, Pinarli G: Long-term effects of chemotherapy on caries formation, dental development, and salivary factors in childhood cancer survivors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104: 781-789, 2007. Goncalves MIR, Radzinsky TC, da Silva NS, Chiari BM, Consonni D: Speech-language and hearing complaints of children and adolescents with brain tumors. Pediatr Blood Cancer 50: 706-708, 2008. Hobbie WL, Moshang T, Carlson CA, Goldmuntz E, Sacks N, Goldfarb SB, Grupp SA, Ginsberg JP: Late effects in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma. Pediatr Blood & Cancer 51: 679-683, 2008. Ad Bardi E, Jenei C, Kiss C: Polymorphism of angiotensin converting enzyme is associated with severe circulatory compromise in febrile neutropenic children with cancer. Pediatr Blood Cancer 45: 217-221, 2005 (1) Hartel C, Deuster M, Lehrnbecher T, Schultz C: Current approaches for risk stratification of infectious complications in pediatric oncology. Pediatr Blood Cancer 49: 767-773, 2007. Ad Losonczy G, Rosenberg N, Kiss C, Kappelmayer J, Vereb G, Kerenyi A, Balogh I, Muszbek L: A novel homozygous mutation (1619delC) in GPllb gene associated with Glanzmann thrombasthenia, the decay of GPllb-mRNA and the synthesis of a truncated GPllb unable to form complex with GPllla. Thromb Haemost 93: 904-909, 2005. (1) Wiwanitkit V: Platelet GPIIb/IIIa receptor: how prone to mutation? Blood Coag: 740741, 2008. Ad. Kiss F, Hevessy Z, Veszprémi A, Katona E, Kiss C, Vereb G, Muszbek L, Kappelmayer J: Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A. Thromb Haemost 96: 176-182, 2006. (2) Sjoberg K, Roth EB, Gustavsson L, Jonsson C, Siman H, Henriksson G, Stenberg P, Lindblom A, Svensson P: Autoimmune markers in lymphoid malignancies. Scand J Immunol 67: 509-515, 2008.
Lin XH, Soderhall K, Soderhall I: Transglutaminase activity in the hematopoietic tissue of a crustacean, Pacifastacus leniusculus, importance in hemocyte homeostasis. BMC Immunol 9, Article Number: 58, doi:10.1186/1471-2172-9-58, 2008. Ad. Muller J, Garami M, Hauser P, Schuler D, Csoka M, Kovacs G, Marosi A, Galantai I, Bekesi A, Kajtar P, Kiss CS, Nagy K, Bartyik K, Masath R, Krivan G: Hungarian experience with Langerhans cell histiocytosis in childhood. Pediatr Hemat Oncol 23: 135142, 2006. (3) Stalemark H, Laurencikas E, Karis J, Gavhed S, Fadeel B, Henter JI: Incidence of Langerhans cell histiocytosis in children: A population-based study. Pediatr Blood Cancer: 76-81, 2008. Donadieu J, Guyot-Goubin A, Clavel J, Thomas C: Clinical presentation and epidemiology of childhood Langerhans cell histiocytosis. 15: 520-522, 2008. Krstovski N, Janic D, Dokmanovic L, Brdar R: Clinical characteristics and survival of children with langerhans cell hystiocytosis. Srpski Arhiv za Celokupno Lekarstvo 136: 514-518, 2008. Ad. Majoros L, Szegedi I, Kardos G, Erdesz C, Konya J, Kiss C: Slow response of invasive Candida krusei infection to amphotericin B in a clinical time-kill study. Eur J Clin Microbiol Infect Dis 25: 803-806, 2006. (1) Pfaller MA, Diekema DJ, Gibbs DL, Newell VA , Nagy E, Dobiasova S, Rinaldi M, Barton R, Veselov A: Candida krusei, a multidrug-resistant opportunistic fungal pathogen: Geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J Clin Microbiol 46: 515-521, 2008. Ad. Renyi I, Bardi E, Udvardi E, Kovacs G, Bartyik K, Kajtar P, Masat P, Nagy K, Galantai I, Kiss C: Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin’s lymphoma. Pathol Oncol Res 13:57-62, 2007. (3) Góth L: Az urátoxidáz- (rasburicas-) terápia lehetséges szövôdménye a hidrogén-peroxid okozta sokk. Orvosi Hetil 149: 1587-1590, 2008. Patzer L: Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol 23: 2159-2173, 2008. Cheng FWT, Xiao J, Li CK: Management of Tumour Lysis Syndrome in Non-Hodgkin Lymphoma. Hong Kong J Paediatr 14: 11-15, 2009. Ad: Kiss F, Buslig J, Szegedi I, Scholtz B, Kappelmayer J, Kiss C: Early relapse after Rituximab chemoimmunotherapy. Pediatr Blood Cancer 50: 372-375, 2008. (1) Dworzak MN, Schumich A, Printz D, Potschger U, Husak Z, Attarbaschi A, Basso G, Gaipa G, Ratei R, Mann G, Gadner H: CD20 up-regulation in pediatric B-cell precursor
acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy. Blood 112: 3982-3988, 2008.
Összes független citáció: 308
